

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent Advances in Understanding and Managing... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-1659/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-1659" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent Advances in Understanding and Managing Cardiomyopathy" />
    
            <meta name="og:title" content="F1000Research Article: Recent Advances in Understanding and Managing Cardiomyopathy.">
            <meta name="og:description" content="Read the latest article version by Paulino Alvarez, WH Wilson Tang, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="12604">
            <meta name="article-id" content="11669">
            <meta name="dc.title" content="Recent Advances in Understanding and Managing Cardiomyopathy">
            <meta name="dc.description" content="Cardiomyopathy is a disease of the heart muscle leading to abnormal structure or function in the absence of coronary artery disease, hypertension, or valvular or congenital heart disease. Currently, cardiomyopathy is the leading diagnosis of heart transplant patients worldwide. Incorporation of next-generation sequencing strategies will likely revolutionize genetic testing in cardiomyopathy. The use of patient-specific pluripotent stem cell-derived cardiomyocytes for disease modeling and therapeutic testing has opened a new avenue for precision medicine in cardiomyopathy. Stem cell therapy, gene therapy, interfering RNA, and small molecules are actively being evaluated in clinical trials.">
            <meta name="dc.subject" content="cardiomyopathy, heart transplant, cardiomyocytes ">
            <meta name="dc.creator" content="Alvarez, Paulino">
            <meta name="dc.creator" content="Tang, WH Wilson">
            <meta name="dc.date" content="2017/09/07">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.11669.1">
            <meta name="dc.source" content="F1000Research 2017 6:1659">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="cardiomyopathy">
            <meta name="prism.keyword" content="heart transplant">
            <meta name="prism.keyword" content="cardiomyocytes ">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/09/07">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="1659">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.11669.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-1659">
            <meta name="citation_title" content="Recent Advances in Understanding and Managing Cardiomyopathy">
            <meta name="citation_abstract" content="Cardiomyopathy is a disease of the heart muscle leading to abnormal structure or function in the absence of coronary artery disease, hypertension, or valvular or congenital heart disease. Currently, cardiomyopathy is the leading diagnosis of heart transplant patients worldwide. Incorporation of next-generation sequencing strategies will likely revolutionize genetic testing in cardiomyopathy. The use of patient-specific pluripotent stem cell-derived cardiomyocytes for disease modeling and therapeutic testing has opened a new avenue for precision medicine in cardiomyopathy. Stem cell therapy, gene therapy, interfering RNA, and small molecules are actively being evaluated in clinical trials.">
            <meta name="citation_description" content="Cardiomyopathy is a disease of the heart muscle leading to abnormal structure or function in the absence of coronary artery disease, hypertension, or valvular or congenital heart disease. Currently, cardiomyopathy is the leading diagnosis of heart transplant patients worldwide. Incorporation of next-generation sequencing strategies will likely revolutionize genetic testing in cardiomyopathy. The use of patient-specific pluripotent stem cell-derived cardiomyocytes for disease modeling and therapeutic testing has opened a new avenue for precision medicine in cardiomyopathy. Stem cell therapy, gene therapy, interfering RNA, and small molecules are actively being evaluated in clinical trials.">
            <meta name="citation_keywords" content="cardiomyopathy, heart transplant, cardiomyocytes ">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Paulino Alvarez">
            <meta name="citation_author_institution" content="Department of Cardiovascular Medicine, Heart and Vascular Institute , Cleveland Clinic, Cleveland, Ohio, USA">
            <meta name="citation_author" content="WH Wilson Tang">
            <meta name="citation_author_institution" content="Department of Cardiovascular Medicine, Heart and Vascular Institute , Cleveland Clinic, Cleveland, Ohio, USA">
            <meta name="citation_author_institution" content="Center for Clinical Genomics, Cleveland Clinic, Cleveland, Ohio, USA">
            <meta name="citation_publication_date" content="2017/09/07">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="1659">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.11669.1">
            <meta name="citation_firstpage" content="1659">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-1659/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-1659.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=12604 /> <input type=hidden id=articleId name=articleId value=11669 /> <input type=hidden id=xmlUrl value="/articles/6-1659/v1/xml"/> <input type=hidden id=xmlFileName value="-6-1659-v1.xml"> <input type=hidden id=article_uuid value=73544a41-b6e5-40f3-9756-87a273bfb60c /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent Advances in Understanding and Managing Cardiomyopathy"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.11669.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.11669.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-1659"
  },
  "headline": "Recent Advances in Understanding and Managing Cardiomyopathy",
  "datePublished": "2017-09-07T16:42:33",
  "dateModified": "2017-09-07T16:42:33",
  "author": [
    {
      "@type": "Person",
      "name": "Paulino Alvarez"
    },    {
      "@type": "Person",
      "name": "WH Wilson Tang"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Cardiomyopathy is a disease of the heart muscle leading to abnormal structure or function in the absence of coronary artery disease, hypertension, or valvular or congenital heart disease. Currently, cardiomyopathy is the leading diagnosis of heart transplant patients worldwide. Incorporation of next-generation sequencing strategies will likely revolutionize genetic testing in cardiomyopathy. The use of patient-specific pluripotent stem cell-derived cardiomyocytes for disease modeling and therapeutic testing has opened a new avenue for precision medicine in cardiomyopathy. Stem cell therapy, gene therapy, interfering RNA, and small molecules are actively being evaluated in clinical trials."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-1659",
            "name": "Recent Advances in Understanding and Managing Cardiomyopathy"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent Advances in Understanding and Managing Cardiomyopathy </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=12604 data-id=11669 data-downloads="" data-views="" data-scholar="10.12688/f1000research.11669.1" data-recommended="" data-doi="10.12688/f1000research.11669.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-1659/v1/pdf?article_uuid=73544a41-b6e5-40f3-9756-87a273bfb60c" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-11669-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-11669-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-11669-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Alvarez P and Tang WW. Recent Advances in Understanding and Managing Cardiomyopathy [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1659 (<a class=new-orange href="https://doi.org/10.12688/f1000research.11669.1" target=_blank>https://doi.org/10.12688/f1000research.11669.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-11669-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=11669 id=track-article-signin-11669 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/11669?target=/articles/6-1659">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=12604 /> <input name=articleId type=hidden value=11669 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent Advances in Understanding and Managing Cardiomyopathy</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Paulino Alvarez<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:tangw@ccf.org" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>WH Wilson Tang</span></a><a href="https://orcid.org/0000-0002-8335-735X" target=_blank id=author-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-8335-735X</div><sup>1,2</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Paulino Alvarez<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:tangw@ccf.org" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>WH Wilson Tang</span></a><a href="http://orcid.org/0000-0002-8335-735X" target=_blank id=mauthor-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-8335-735X</div><sup>1,2</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 07 Sep 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.11669.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Cardiovascular Medicine, Heart and Vascular Institute , Cleveland Clinic, Cleveland, Ohio, USA<br/> <sup>2</sup> Center for Clinical Genomics, Cleveland Clinic, Cleveland, Ohio, USA<br/> <p> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=25465-25793></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=4703-25794></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Cardiomyopathy is a disease of the heart muscle leading to abnormal structure or function in the absence of coronary artery disease, hypertension, or valvular or congenital heart disease. Currently, cardiomyopathy is the leading diagnosis of heart transplant patients worldwide. Incorporation of next-generation sequencing strategies will likely revolutionize genetic testing in cardiomyopathy. The use of patient-specific pluripotent stem cell-derived cardiomyocytes for disease modeling and therapeutic testing has opened a new avenue for precision medicine in cardiomyopathy. Stem cell therapy, gene therapy, interfering RNA, and small molecules are actively being evaluated in clinical trials. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> cardiomyopathy, heart transplant, cardiomyocytes </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> WH Wilson Tang (<a href="mailto:tangw@ccf.org">tangw@ccf.org</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> WH Wilson Tang </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> The authors declare that they have no competing interests. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> WT is supported by grants from the National Institutes of Health (R01HL103866, P20HL113452, R01DK106000, R01HL126827). <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp;  2017 Alvarez P and Tang WW. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Alvarez P and Tang WW. Recent Advances in Understanding and Managing Cardiomyopathy [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1659 (<a href="https://doi.org/10.12688/f1000research.11669.1" target=_blank>https://doi.org/10.12688/f1000research.11669.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 07 Sep 2017, <b>6</b>(F1000 Faculty Rev):1659 (<a href="https://doi.org/10.12688/f1000research.11669.1" target=_blank>https://doi.org/10.12688/f1000research.11669.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 07 Sep 2017, <b>6</b>(F1000 Faculty Rev):1659 (<a href="https://doi.org/10.12688/f1000research.11669.1" target=_blank>https://doi.org/10.12688/f1000research.11669.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d93475e167>Introduction</h2><p class="" id=d93475e170>Cardiomyopathy is a disease of the heart muscle leading to abnormal structure or function in the absence of coronary artery disease, hypertension, or valvular or congenital heart disease<sup><a href="#ref-1">1</a></sup>. Morphological subtypes include dilated cardiomyopathy, hypertrophic cardiomyopathy (HCM), arrhythmogenic right ventricular (RV) cardiomyopathy, left ventricular (LV) non-compaction, and restrictive cardiomyopathy. The global number of deaths and disability attributed to cardiomyopathy and myocarditis has steadily increased<sup><a href="#ref-2">2</a>,<a href="#ref-3">3</a></sup>. Cardiomyopathy represents the leading cause of cardiac transplantation<sup><a href="#ref-4">4</a></sup>. The hereditary nature of most cardiomyopathies creates an opportunity for early detection through family screening but also has the potential for misdiagnosis<sup><a href="#ref-5">5</a></sup>. How we classify, detect, and treat cardiomyopathy in 2017 and what is on the horizon are the focus of our review. In addition, infiltrative myocardial disease as an important differential diagnosis will be discussed when appropriate.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d93475e195>Classification</h2><p class="" id=d93475e198>As stated in the Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies, a classification is an attempt to bridge the gap between ignorance and knowledge<sup><a href="#ref-6">6</a></sup>. In that document, the following morphological and functional subtypes were recognized:</p><div class=list><a name=d93475e205 class=n-a></a><ul><li><p id=d93475e209>Dilated cardiomyopathy: characterized by ventricular dilatation and impaired contraction</p></li><li><p id=d93475e215>HCM: characterized by LV and/or RV hypertrophy, which is usually asymmetric and involves the interventricular septum</p></li><li><p id=d93475e221>Restrictive cardiomyopathy: characterized by restrictive filling and reduced diastolic volume of either or both ventricles with normal or near-normal systolic function and wall thickness</p></li><li><p id=d93475e227>Arrhythmogenic RV cardiomyopathy: progressive fibro-fatty replacement of RV myocardium, initially with typical regional and later global right and some LV involvement, with relative sparing of the septum</p></li><li><p id=d93475e233>Unclassified cardiomyopathies: unclassified cardiomyopathies include a few cases that do not fit readily into any group</p></li></ul></div><p class="" id=d93475e238>The 2006 American Heart Association (AHA) classification divided cardiomyopathies into primary, which are solely or predominantly confined to heart muscle, and secondary cardiomyopathies, which show pathological myocardial involvement as part of generalized systemic (multi-organ) disorders<sup><a href="#ref-7">7</a></sup>. Primary cardiomyopathies are subclassified into genetic, mixed (genetic and non-genetic), and acquired. In 2007, the European Society of Cardiology proposed a new classification in which each morpho-functional subtype was subclassified according to familial/genetic and non-familial/non-genetic forms. The familial/genetic forms were subdivided into unidentified gene defect and specific disease subtype, and the non-familial/non-genetic into idiopathic and specific disease subtype<sup><a href="#ref-8">8</a></sup>. Specific cardiomyopathies is used to describe cardiomyopathies associated with specific cardiac or systemic disorders. For example, a recent AHA document reviews diagnostic and treatment strategies for specific cardiomyopathies such as cardiac amyloidosis, cardiotoxins, peripartum cardiomyopathy, cardiac sarcoidosis, myocarditis, autoimmune cardiomyopathy, endocrine and metabolic cardiomyopathies, and genetic cardiomyopathies<sup><a href="#ref-9">9</a></sup>. Nevertheless, the application of morphological criteria can be misleading because diseases with similar imaging findings can have completely different pathophysiological mechanisms (for example, HCM and Fabry disease)<sup><a href="#ref-10">10</a></sup>.</p><p class="" id=d93475e257>The MOGE(S) classification of cardiomyopathies proposes a descriptive phenotype and genotype nosology system that incorporates the following five attributes: morpho-functional phenotype, organ(s) involvement, genetic inheritance pattern, etiological annotation including genetic defect or underlying disease/substrate, and functional status of the patient and disease process using both the American College of Cardiology/AHA stage and New York Heart Association functional class. The MOGE(S) nosology system is the most recently proposed<sup><a href="#ref-1">1</a></sup>. The use of a web-based application facilitates the implementation of this classification system (<a target=xrefwindow href="http://moges.biomeris.com/moges.html" id=d93475e263>http://moges.biomeris.com/moges.html</a>) (<a href="#f1">Figure 1</a>).</p><div class="fig panel clearfix"><a name=f1 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/12604/0fe97ba4-91d4-4701-b6af-8956c87cfc7b_figure1.gif"><img alt="0fe97ba4-91d4-4701-b6af-8956c87cfc7b_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/12604/0fe97ba4-91d4-4701-b6af-8956c87cfc7b_figure1.gif"></a><div class=caption><h3>Figure 1. Example of MOGES classification utilization.</h3><p id=d93475e281>Family diagram: square, male; circle, female; red, history of sudden cardiac death (SCD) or hypertrophic cardiomyopathy (HCM); blue, no history of SCD or HCM. Index case: *Age at diagnosis or SCD. Since no genotyping was performed, the mode of inheritance cannot be determined with certainty. FC, functional class; ICD, implantable cardioverter defibrillator; NYHA, New York Heart Association; s/p, status post.</p></div></div><p class="" id=d93475e288>Because the presence of a morphological abnormality is not synonymous with cardiomyopathy (for example, imaging criteria for LV non-compaction may be seen in more than 10% of persons free from cardiovascular disease), and the risk of developing genotype-positive and phenotype-negative cardiomyopathy is unknown, the clinician faces major challenges when evaluating an individual patient<sup><a href="#ref-11">11</a>,<a href="#ref-12">12</a></sup>. Quarta <i>et al</i>. recently proposed a framework to navigate this uncertainty<sup><a href="#ref-13">13</a></sup>. Their major criteria to diagnose cardiomyopathy include 1- Marked morphological abnormalities, clearly outside the limits of physiological remodeling, 2- Clear evidence of global or regional LV (and/or RV) systolic or diastolic dysfunction, or dynamic LV outflow obstruction at rest or on effort, 3- Frequent (&gt;10,000 beats per 24 h) and repetitive ventricular ectopic beats, which do not subside or tend to increase with exercise and/or are polymorphic, or runs of sustained or nonsustained ventricular tachycardia, 4- Symptoms such as dyspnea, angina, pre-syncopal or syncopal episodes of non-vasovagal nature (particularly if upon or after exertion or after a meal), or reduced performance as assessed by cardiorespiratory testing, 5- A positive genetic test  when available and robust  or specific family history of cardiomyopathy and/or juvenile heart failure or sudden death; if unknown or not investigated, judgment should be suspended until relatives have been screened.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d93475e308>Detection of abnormal structure and function</h2><div class=section><a name=d93475e311 class=n-a></a><h3 class=section-title>Non-invasive diagnostic modalities</h3><p class="" id=d93475e316>Echocardiography is often the first diagnostic modality used when cardiomyopathy is suspected. Although morphological two-dimensional echocardiography and ejection fraction are key elements for phenotype characterization, advanced echocardiographic modalities such as tissue Doppler and strain have made possible the detection of early stages of myocardial dysfunction.</p><p class="" id=d93475e319>Abnormal tissue Doppler signals may help to identify the presence of HCM in the pre-hypertrophic stage and to differentiate athletes heart from HCM<sup><a href="#ref-14">14</a>,<a href="#ref-15">15</a></sup>. Machine learning models that incorporate longitudinal strain, among other volumetric and mechanical function variables, may help in the distinction between physiologic and pathologic hypertrophy<sup><a href="#ref-16">16</a></sup>. In patients with sarcoidosis but without evidence or history of cardiac involvement, impairment of global LV longitudinal strain was associated with increased risk of cardiac events<sup><a href="#ref-17">17</a></sup>. In patients exposed to anthracyclines, a relative percentage reduction in global longitudinal strain of at least 15% early during the course of therapy predicts the development of cardiotoxicity<sup><a href="#ref-18">18</a></sup>. Abnormal regional patterns of strain are useful for the identification of specific cardiomyopathies such as apical sparring usually seen in patients with preserved ejection fraction heart failure due to cardiac amyloidosis or apical compromise in patients with apical HCM<sup><a href="#ref-19">19</a>,<a href="#ref-20">20</a></sup>. In patients with obstructive HCM refractory to medical therapy who underwent septal myectomy, basal septal (myocardium removed during myectomy) mean systolic strain and diastolic strain rate correlated with <i>in vitro</i> measured myocardial contractile performance<sup><a href="#ref-21">21</a></sup>. Longitudinal strain and early diastolic strain pre-transplant showed significant correlations with mRNA expression of titin isoforms, sarcoplasmic reticulum Ca<sup>2+</sup> ATPase, and phosphorylated phospholamban in dilated cardiomyopathy<sup><a href="#ref-22">22</a></sup>.</p><p class="" id=d93475e363>Vector flow mapping, a novel method of Doppler signal analysis, has shown that the cause of systolic anterior motion of the mitral valve and obstruction in HCM is early systolic ejection flow or isovolumetric vortical flow impacting the posterior aspect of the mitral valve and not Venturi forces related to high flows in the LV outflow tract<sup><a href="#ref-23">23</a></sup>. Also, vortex formation has been correlated with functional capacity in a pilot study<sup><a href="#ref-24">24</a></sup>.</p><p class="" id=d93475e374>Cardiac magnetic resonance imaging has become an integral part of cardiomyopathy evaluation and risk stratification. Apicalbasal bundles and mitral valve abnormalities (for example, increased anterior mitral valve length) have emerged as new phenotypic markers of HCM that are observed also in the pre-hypertrophic stage<sup><a href="#ref-25">25</a>,<a href="#ref-26">26</a></sup>. Fractal dimension, a parameter used to quantify myocardial muscle trabecular complexity, is increased in HCM mutation carriers without LV hypertrophy<sup><a href="#ref-27">27</a></sup>. LV structural abnormalities in patients with arrhythmogenic RV dysplasia have also been described with increased frequency<sup><a href="#ref-28">28</a>,<a href="#ref-29">29</a></sup>.</p><p class="" id=d93475e396>The presence, distribution, and burden of macroscopic myocardial scar tissue as measured by late gadolinium enhancement (LGE) are of particular importance. In a meta-analysis of 2,390 patients with various types of dilated cardiomyopathies, LGE was independently associated with higher risk of sudden cardiac death (SCD) and ventricular arrhythmias<sup><a href="#ref-30">30</a></sup>. In HCM, for every 10% increase in LGE, there was a 40% increase in SCD events. Of particular importance is that, in patients who were considered to be at low risk of SCD by traditional risk stratification systems, the presence of LGE of at least 15% of the myocardial mass had a five-year risk of SCD of 6%<sup><a href="#ref-31">31</a></sup>. In patients with Duchenne muscular dystrophy, the presence of LGE is associated with a progressive decline in LV ejection fraction (LVEF), and the magnitude of this decline is proportional to the number of myocardial segments with LGE<sup><a href="#ref-32">32</a></sup>. In patients with cardiac amyloidosis, cardiac magnetic resonance imaging shows a characteristic pattern of global subendocardial LGE; in addition, patients with systemic AL amyloidosis show markedly increased non-contrast T1 relaxation times in the myocardium when compared with healthy controls and patients with aortic stenosis<sup><a href="#ref-33">33</a>,<a href="#ref-34">34</a></sup>.</p><p class="" id=d93475e418>Extracellular volume fraction, which includes both diffuse and macroscopic patchy fibrosis using the modified looklocker inversion (MOLLI) recovery method, has been shown to correlate better with regional LV myocardial velocities than ejection fraction in patients with non-ischemic cardiomyopathy<sup><a href="#ref-35">35</a></sup>. Increased interstitial fibrosis is a marker of subclinical cardiac involvement in patients who are carriers of lamin A/C gene mutation<sup><a href="#ref-36">36</a></sup>.</p><p class="" id=d93475e429>Recently, <i>in vivo</i> diffusion tensor cardiac magnetic resonance has been shown to characterize the microstructural dynamics by analyzing sheetlet (laminar microstructures 510 cardiomyocyte thick) mobility and orientation during the cardiac cycle. Reduced mobility is seen in both dilated cardiomyopathy and HCM. Nevertheless, in HCM, abnormal diastolic conformation is present, whereas abnormal systolic conformation characterizes dilated cardiomyopathy<sup><a href="#ref-37">37</a></sup>.</p><p class="" id=d93475e439>The use of four-dimensional (4D) flow (3D+time=4D) allows the generation of 3D streamlines that permit the analysis of different flow patterns. The application of this technique in patients with HCM, with and without obstruction, revealed abnormal flow patterns in the ascending aorta in both groups. The significance of these findings is unknown<sup><a href="#ref-38">38</a></sup>.</p><p class="" id=d93475e446>Cardiac positron emission tomography evaluates the presence of perfusion and metabolic abnormalities. In cardiac sarcoidosis, the coexistence of myocardial perfusion defects and increased focal metabolic activity, which reflects active disease, is associated with increased risk of death and ventricular tachycardia<sup><a href="#ref-39">39</a></sup>. <sup>99m</sup>Technetium phosphate derivatives can bind to transthyretin in the myocardium and can be used to identify wild-type and mutant transthyretin-related amyloidosis. If amyloidosis is suspected and a scan is negative, this favors the diagnosis of light-chain amyloidosis<sup><a href="#ref-40">40</a></sup>.</p></div><div class=section><a name=d93475e461 class=n-a></a><h3 class=section-title>Invasive diagnostics</h3><p class="" id=d93475e466>Invasive hemodynamic evaluation is particularly useful to differentiate restriction from constriction. In this case, simultaneous pressure measurements of the right and left ventricles are performed ideally with high-fidelity conductance catheters to evaluate for the presence of enhanced ventricular interaction and systolic area index in the case of constrictive pericarditis. Careful evaluation is necessary to avoid missing the diagnosis of a potentially reversible condition<sup><a href="#ref-41">41</a></sup>.</p></div><div class=section><a name=d93475e474 class=n-a></a><h3 class=section-title>Endomyocardial biopsy</h3><p class="" id=d93475e479>Transvenous endomyocardial biopsy is an invasive procedure with a reported major complication rate (for example, tamponade) of less than 1%<sup><a href="#ref-42">42</a></sup>. The importance of tissue-based diagnosis for accurate prognostication in patients with unexplained cardiomyopathy has been known for a long time<sup><a href="#ref-43">43</a></sup>. The procedure is usually performed by using fluoroscopic guidance, with increasing interest in the use of 3D echocardiography to decrease the chances of RV free wall biopsy<sup><a href="#ref-44">44</a></sup>. The endomyocardial biopsy sensitivity can reach almost 100% in amyloidosis or approximately 30% in focal diseases such as sarcoidosis<sup><a href="#ref-45">45</a>,<a href="#ref-46">46</a></sup>. Usually, RV biopsy is performed, but the biventricular approach has been reported to increase diagnostic yield with a similar major complication rate in very experienced operators<sup><a href="#ref-47">47</a></sup>. The performance of voltage mapping to guide endomyocardial biopsy has been described to increase diagnostic yield in patients with focal myocardial diseases such as sarcoidosis or lymphocytic myocarditis<sup><a href="#ref-48">48</a></sup>.</p><p class="" id=d93475e510>In myocarditis, the use of immunohistochemistry to characterize inflammatory mechanisms, molecular techniques such as polymerase chain reaction to detect viral genomes, andmore recentlythe analysis of non-coding transcripts such as microRNA hold the promise to continue to improve prognostication and treatment in this potentially lethal condition<sup><a href="#ref-49">49</a>,<a href="#ref-50">50</a></sup>. Interestingly, the presence of focal derangement or diffuse lysis of myofilaments observed by electron microscopy in the endomyocardial samples obtained from the posterolateral LV wall of patients with dilated cardiomyopathy admitted with acutely decompensated heart failure was a strong predictor of death or heart failure re-hospitalization during a follow-up period of 4.9  3.9 years<sup><a href="#ref-51">51</a></sup>.</p></div><div class=section><a name=d93475e525 class=n-a></a><h3 class=section-title>Device therapy/roles of electrophysiology study/ablation</h3><p class="" id=d93475e530>Implantable cardioverter defibrillators are indicated for the prevention of SCD in selected patients with heart failure and reduced ejection fraction and HCM at high risk of sudden death<sup><a href="#ref-52">52</a>,<a href="#ref-53">53</a></sup>. In cardiac sarcoidosis, the use of programmed electrical stimulation may assist in SCD risk stratification<sup><a href="#ref-54">54</a></sup>. Approximately 30% of patients will fail to respond to cardiac resynchronization therapy, and many causes or associated factors have been identified (for example, atrial fibrillation and less than 90% of biventricular pacing)<sup><a href="#ref-55">55</a></sup>. A novel mechanism to potentially improve cardiac resynchronization response is pacemaker-induced transient asynchrony. Six hours of daily RV pacing halted LV dilatation and myocyte dysfunction in a tachycardia-induced cardiomyopathy model in dogs<sup><a href="#ref-56">56</a></sup>. The recognition of a significant premature ventricular contraction burden (&gt;24%) should increase the suspicion of premature ventricular contraction-induced cardiomyopathy; this is important because ablation of the ectopic foci may lead to improvement of cardiac function<sup><a href="#ref-57">57</a></sup>.</p><p class="" id=d93475e556>Electro-anatomic scar patterns differentiate RV outflow tachycardia from arrhythmogenic RV/dysplasia (ARVD) or cardiomyopathy. In ARVD, dominant sub-tricuspid scars with extensions toward the apex and RV outflow tract (RVOT) are seen where, in RVOT, isolated RVOT scar may be seen<sup><a href="#ref-58">58</a></sup>. The use of electro-anatomical mapping to guide endomyocardial biopsy has been previously described<sup><a href="#ref-48">48</a></sup>.</p></div><div class=section><a name=d93475e569 class=n-a></a><h3 class=section-title>Genetic evaluation and testing</h3><p class="" id=d93475e574>Most cardiomyopathies are monogenic disorders. Unexplained cardiomyopathy, family history of SCD or cardiomyopathy, and electrocardiogram suggesting an inherited arrhythmia should trigger genetic evaluation<sup><a href="#ref-59">59</a></sup>.</p><p class="" id=d93475e581>The first fundamental step is a family history using a standardized template (for example, <a target=xrefwindow href="https://familyhistory.hhs.gov/FHH/html/index.html" id=d93475e583>https://familyhistory.hhs.gov/FHH/html/index.html</a>) if possible. Early consultation with genetics professionals is encouraged. It is important to convey the reason for consultation and potential implications to the patient. In cardiomyopathy, the main roles of genetic testing are to aid in the identification of family members at risk for the condition and to inform screening strategies.</p><p class="" id=d93475e587>In a large study of 312 patients with dilated cardiomyopathy, a truncating titin mutation was present in one-fourth of familial and in 18% of sporadic cases. Truncating titin mutations were observed in only 1% and 3% of patients with HCM (n = 231) and controls (n = 249), respectively<sup><a href="#ref-60">60</a></sup>.</p><p class="" id=d93475e594>Coppini <i>et al</i>. have reported that patients with HCM who have a mutation affecting the thin filament are at increased risk of developing LV dysfunction, heart failure, and severe diastolic dysfunction when compared with patients with thick filament mutations<sup><a href="#ref-61">61</a></sup>. Nevertheless, it is important to recognize that HCM is a disease where gene-phenotype correlations are more notable for their absence than presence.</p><p class="" id=d93475e605>Studies showing the impact of genotype in prognosis in ARVD/C have been reported. Patients with ARVD/C and carriers of a desmosomal gene mutation have worse outcomes when compared with those with titin mutations<sup><a href="#ref-62">62</a></sup>. In addition, in a large cohort of patients with ARVD/C who had pathogenic mutations, desmoplakin mutations were overrepresented in patients with SCD/ventricular fibrillation as a presenting symptom<sup><a href="#ref-63">63</a></sup>. In the same study, the negative prognostic implications of having more than one pathogenic mutation and male sex were also reported.</p><p class="" id=d93475e616>Future applications may include the development of genotype-specific therapies, and pilot studies of pharmacologic therapies in the pre-phenotype phase have been completed (see below). If concomitant congenital malformations are present and a chromosomal disorder is suspected, a chromosomal microarray analysis should be considered. When cardiomyopathy is the main feature and genetic abnormalities at the nucleotide level are suspected, several options are available. Gene panels directed to specific morpho-functional phenotypes that screen for pathogenic mutations are available. Results of genetic testing have five categories: pathogenic, likely pathogenic, variables of unknown significance, likely benign, and benign. The diagnostic yield of these panels is variable and ranges from 50 to 60% in ARVD and from 20 to 30% in dilated cardiomyopathy<sup><a href="#ref-64">64</a></sup>. Pan-cardiomyopathy panels have not been shown to increase the diagnostic sensitivity in HCM<sup><a href="#ref-65">65</a></sup>. The decrease in cost and turn-over time of next-generation sequencing strategies, including exome (sequences the genes involved in protein synthesis) and whole genome (sequences both coding and non-coding), has led some institutions to adopt this strategy. From a clinical standpoint, one of the main challenges of non-directed second-generation sequencing is the increase in the identification of variants of unknown significance; this is non-actionable genetic information<sup><a href="#ref-66">66</a></sup>. Nevertheless, recent reports combining these techniques with functional studies show encouraging results in detecting new pathogenic mutations<sup><a href="#ref-67">67</a></sup>. The creation of large repositories of genetic and phenotypic information, along with powerful analytic techniques, will shape the implementation of next-generation sequencing<sup><a href="#ref-68">68</a></sup>.</p><p class="" id=d93475e639>The incorporation of genetic information in epidemiologic studies with long-term follow-up has opened a new chapter in understanding the natural history of disease. Amyloidosis is a systemic disease due to the deposition of misfolded proteins that may affect the heart. There are two main forms of cardiac amyloid disease: AL amyloidosis due to immunoglobulin light chains and transthyretin amyloidosis. Patients with transthyretin may have wild-type (previously called senile amyloidosis) or genetic variants. The V122I variant, where isoleucine is substituted for valine, has a prevalence of approximately 3% in African-Americans and is the most common point mutation associated with hereditary transthyretin amyloidosis. Carriers of this mutation were believed to have an increased risk of death. In a study that included 3,856 African-Americans, 124 carriers were detected, and over a follow-up period of 21.5 years, those patients were at increased risk of heart failure development, but there were no statistically significant differences in mortality<sup><a href="#ref-69">69</a></sup>.</p><p class="" id=d93475e646>Other genetic variants include Val30Met (Any, Portuguese, Spanish) and Thr60Ala (Irish), both of which commonly affect the nerves and the heart. Nevertheless, early cardiac involvement is not as frequent in Val30Met<sup><a href="#ref-70">70</a></sup>.</p></div><div class=section><a name=d93475e654 class=n-a></a><h3 class=section-title>Precision medicine and emerging therapeutic strategies</h3><p class="" id=d93475e659>Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability (genes, environmental factors, and lifestyle) and is of particular relevance for cardiomyopathy<sup><a href="#ref-71">71</a></sup>. In this regard, the development of transcription factor-mediated reprogramming techniques, which allowed the production of human-induced pluripotent stem cells (hiPSCs), represents a major step forward<sup><a href="#ref-72">72</a></sup>. Protocols for the production of patient-specific pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are available<sup><a href="#ref-73">73</a></sup>. Applications of hiPSC-CMs include disease modeling, regenerative medicine, drug discovery, and toxicity screening<sup><a href="#ref-74">74</a></sup>. For hiPSC-CMs that carry a mutation in cardiac transcription, factor TBX20 develops phenotypic characteristics of LV non-compaction cardiomyopathy. In this experiment, abnormal transforming growth factor-beta (TGF-) signaling was detected. Inhibition of TGF- signaling and genomic correction of the TBX20 mutation were sufficient to reverse the phenotype<sup><a href="#ref-75">75</a></sup>. Using patient-derived hiPSC-CMs, the mechanisms by which titin mutations cause sarcomere insufficiency in dilated cardiomyopathy were explored<sup><a href="#ref-76">76</a></sup>. In another exciting experiment, hiPSC-CMs from patients who experience doxorubicin cardiac toxicity were more sensitive to <i>in vitro</i> doxorubicin toxicity than hiPSC-CMs of patients who did not experience doxorubicin toxicity. Several mechanisms were identified, including decreased cell viability, impaired mitochondrial function, metabolic derangements, and increased production of reactive oxygen species<sup><a href="#ref-77">77</a></sup>. This finding suggests that hiPSC-CMs could be a potential tool to predict chemotherapy-induced cardiotoxicity.</p><p class="" id=d93475e694>Mutation silencing therapy in a murine model of HCM has shown that irreversible triggers to phenotypic expression occur early in development (&lt;6 weeks of life)<sup><a href="#ref-78">78</a></sup>. One of the advantages of detecting genotype-positive phenotype-negative patients is the potential to intervene and alter the trajectory of disease. In a pilot and first-of-its-kind study, 38 patient carriers of pathogenic sarcomere mutations associated with HCM, but without LV hypertrophy, were randomly assigned to diltiazem or placebo. Patients who received diltiazem showed stable LV diameter and mean thickness-to-dimension ratio compared with control patients who showed a decrease and an increase in LV diameter and mean thickness-to-dimension ratio, respectively<sup><a href="#ref-79">79</a></sup>.</p><p class="" id=d93475e705>There has been pre-clinical evidence of the potential benefit of renin-angiotensin axis inhibition in modifying the course of HCM in a randomized controlled trial that included 133 patients with obstructive and non-obstructive cardiomyopathy, but the administration of losartan, though well tolerated, did not show significant difference when compared with placebo with regard to the primary endpoint (change in LV mass as measured by computed tomography or cardiac magnetic resonance imaging)<sup><a href="#ref-80">80</a>,<a href="#ref-81">81</a></sup>.</p><p class="" id=d93475e715>The presence of LGE has been used to identify patients with Duchenne and Becker muscular dystrophies who have normal LVEF but who are at higher risk of developing cardiac dysfunction. In this particular patient population, treatment with eplerenone (Duchenne) and angiotensin-converting enzyme inhibitor (Duchenne and Becker) delayed and attenuated adverse cardiac remodeling<sup><a href="#ref-82">82</a>,<a href="#ref-83">83</a></sup>.</p><p class="" id=d93475e726>The value of moderate exercise training in selected patients with HCM has been recently evaluated in a pilot randomized trial. After 16 weeks, patients randomly assigned to the unsupervised exercise protocol had a small but significant increase in exercise capacity as measured by cardiopulmonary exercise testing with no significant adverse events<sup><a href="#ref-84">84</a></sup>. In non-ischemic dilated cardiomyopathy, myocardial blood flow at rest and after cold pressor test improved after 12 weeks of cardiac rehabilitation<sup><a href="#ref-85">85</a></sup>.</p></div><div class=section><a name=d93475e738 class=n-a></a><h3 class=section-title>Target therapy/small molecules</h3><p class="" id=d93475e743>MYK-461, a small molecule which binds to myosin decreasing its ATPase activity in a dose-dependent manner and consequently sarcomere contractility, has been shown to prevent the development of the HCM phenotype in a murine model of HCM if administered early (815 weeks of age) in the pre-hypertrophic stage, and it partially reversed structural abnormalities if administered once the hypertrophic phenotype became manifest<sup><a href="#ref-86">86</a></sup>. The intravenous administration of MYK-461 decreased contractility and eliminated systolic anterior motion of the mitral valve, relieving outflow obstruction in a feline model of HCM<sup><a href="#ref-87">87</a></sup>. Initial experience in humans shows encouraging results with a dose-dependent reduction of contractility and abolition of LV outflow gradients in two patients. Of note, one patient experienced asystole after receiving the highest dose studied, but it resolved without intervention<sup><a href="#ref-88">88</a></sup>.</p><p class="" id=d93475e758>Noonan syndrome and Noonan syndrome with multiple lentigines (formerly LEOPARD syndrome) as other RASopathies are autosomal dominant disorders caused by germline missense mutations of the Ras/mitogen-activated protein kinase (Ras/MAPK) signaling pathway; one of the phenotypic abnormalities is the development of HCM. A hyper-tyrosil phosphorylated form of protein-zero related (PZR) is present in the hearts of mice with those conditions. Yi <i>et al</i>. described that, in a murine model of Noonan syndrome and Noonan syndrome with lentigines, the administration of low-dose dasatinib (tyrosine kinase inhibitor) improves cardiomyocyte contractility, reduces fibrosis, andif administered <i>in utero</i>rescues HCM phenotype<sup><a href="#ref-89">89</a></sup>.</p><p class="" id=d93475e771>The <i>LMNA</i> gene encodes lamins C and A that are the major constituents of nuclear lamina, a proteinaceous meshwork that gives structural support to the nucleus and enables correct gene expression and DNA repair. Lamins A and C are generated through alternative splicing<sup><a href="#ref-90">90</a></sup>. Laminopathies are a diverse group of disorders caused by <i>LMNA</i> gene mutations and the most common one is dilated cardiomyopathy<sup><a href="#ref-91">91</a></sup>. Current pathophysiological mechanisms of <i>LMNA</i> mutations include increased susceptibility to mechanical stress, altered gene expression, and accumulation of pre-lamin A<sup><a href="#ref-92">92</a>,<a href="#ref-93">93</a></sup>. The feasibility of alternative splicing modulation with antisense oligonucleotides to increase lamin C and decrease pre-lamin A accumulation has been successfully tested in fibroblasts of patients with Hutchinson-Gilford progeria syndrome and a mouse model<sup><a href="#ref-94">94</a></sup>. The recognition of abnormal activation of the MAPK and Akt/mTOR (mammalian target of rapamycin) pathways has led to promising experimental data using protein kinase inhibitors and mTOR inhibitors, respectively, to block the development of cardiac dysfunction in mouse models of laminopathies<sup><a href="#ref-95">95</a>,<a href="#ref-96">96</a></sup>.</p><p class="" id=d93475e810>Constitutive activation of mammalian target of rapamycin complex 1 (MTOR-1) by tuberous sclerosis mutations is a recognized mechanism of tumor formation in this syndrome. In a patient with tuberous sclerosis and cardiomyopathy in which phosphorylation of ribosomal protein S6 (marker of MTOR-1 activation) was detected in endomyocardial biopsy, the administration of everolimus (MTOR inhibitor) led to improvement in systolic function and LV dimensions<sup><a href="#ref-97">97</a></sup>.</p></div><div class=section><a name=d93475e818 class=n-a></a><h3 class=section-title>Gene therapy in cardiomyopathy and heart failure</h3><p class="" id=d93475e823>Increased understanding of the molecular mechanisms of heart failure have led to the recognition of potential targets for gene therapy<sup><a href="#ref-98">98</a></sup>. Increasing cardiac contractility by targeting molecules related to calcium cycling (sarcoplasmic reticulum Ca<sup>2+</sup> ATPase, or SERCA2a) or increasing beta-adrenergic system function (human adenylyl cyclase type 6, or hAC6) and enhancing stem cell tissue repair by increasing the expression of stem cell-derived factor 1 (SDF-1) have undergone clinical trial evaluation<sup><a href="#ref-99">99</a></sup>. Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2) that included 250 patients with NYHA (New York Heart Association) functional class IIIV and LVEF of not more than 35% who were randomly assigned to intracoronary infusion of adeno-associated virus loaded with SERCA gene versus placebo failed to achieve the primary endpoint of recurrent events (hospital admission because of heart failure or ambulatory treatment for worsening heart failure) with a median follow-up of 17.5 months. Nevertheless, the absence of significant adverse events is promising and has helped to enhance the interest in this therapeutic strategy<sup><a href="#ref-100">100</a></sup>. A recent phase II trial has shown a significant increase in LVEF in patients who received intracoronary delivery of adenovirus hAC6 when compared with placebo<sup><a href="#ref-101">101</a></sup>.<i></i></p></div><div class=section><a name=d93475e848 class=n-a></a><h3 class=section-title>Cell therapy in non-ischemic cardiomyopathy</h3><p class="" id=d93475e853>Intravenous allogenic mesenchymal stem cells were shown to be safe and effective in improving the 6-minute walk test and quality-of-life measures in patients with non-ischemic cardiomyopathy with a mean LVEF of 31%. There was no evidence of myocardial scar as measured by LGE in patients on maximal medical therapy<sup><a href="#ref-102">102</a></sup>. In a previous article, trans-endocardial injection of allogenic mesenchymal stem cells was superior to auto-mesenchymal stem cells in terms of efficacy (LVEF improvement and 6-minute walk test) and safety with an extremely low risk of allosensitization<sup><a href="#ref-103">103</a></sup>. A phase I clinical trial of transplantation of scaffold-free cell sheets derived from autologous muscle to the epicardial surface through left thoracotomy in patients with severe LV dysfunction due to ischemic (n = 15) or dilated cardiomyopathy (n = 12) has shown promising results regarding safety with no major procedural adverse events and efficacy with improvement in symptoms, 6-minute walk test, and LVEF<sup><a href="#ref-104">104</a></sup>.</p></div><div class=section><a name=d93475e869 class=n-a></a><h3 class=section-title>New developments in treating amyloidosis</h3><p class="" id=d93475e874>Novel therapies that block abnormal protein synthesis such as small interfering RNA and antisense oligonucleotides are undergoing phase III clinical trial evaluation in transthyretin amyloidosis, the most common form of cardiac amyloidosis<sup><a href="#ref-70">70</a></sup>. In light-chain amyloidosis, the use of an amyloid fibril-reactive chimeric monoclonal antibody is undergoing clinical trial evaluation. This approach was shown to be safe in a phase I clinical trial that included six patients with refractory amyloidosis. Those three patients showed organ response: two cardiac and one gastrointestinal<sup><a href="#ref-105">105</a></sup>.</p></div><div class=section><a name=d93475e887 class=n-a></a><h3 class=section-title>Immune modulation in heart failure</h3><p class="" id=d93475e892>Inflammation is a key player in the development and progression of heart failure<sup><a href="#ref-106">106</a></sup>. Anti- tumor necrosis factor therapy has been shown to be ineffective and even potentially harmful in this patient population in large randomized clinical trials<sup><a href="#ref-107">107</a></sup>. Non-specific immunomodulation was also unsuccessful in reducing death from any cause and hospitalization from cardiovascular causes<sup><a href="#ref-108">108</a></sup>. There is increasing interest in the manipulation of the innate immune system<sup><a href="#ref-109">109</a></sup>. Toll-like receptors, which are the primary receptors of the innate immune system and related molecules (for example, myeloid differentiation 1), constitute attractive targets that are the subject of intense research<sup><a href="#ref-110">110</a>,<a href="#ref-111">111</a></sup>. In addition, the recognition that embryonic-derived macrophages that have anti-inflammatory properties and promote tissue regeneration are replaced in heart failure with monocyte-derived macrophages that have pro-inflammatory properties may open a new pathway to cardiac recovery<sup><a href="#ref-112">112</a></sup>.</p></div><div class=section><a name=d93475e924 class=n-a></a><h3 class=section-title>New surgical approaches</h3><p class="" id=d93475e929>In HCM, surgical septal myectomy often resolves mitral regurgitation related to systolic anterior motion of the mitral valve; nevertheless, some patients need additional mitral valve procedures such as mitral valve repair or replacement<sup><a href="#ref-113">113</a></sup>. A novel operative technique that consists of trans-aortic cutting of thickened secondary mitral valve chordae seems to be effective in relieving outflow tract obstruction in patients with HCM and mild septal thickness with the advantage of avoiding additional mitral valve procedures<sup><a href="#ref-114">114</a></sup>. This technique is based on the pathophysiological hypothesis that fibrotic and retracted secondary chordae may cause abnormal tethering of the anterior mitral valve and favor the displacement of the slack portions of the leaflet (and attached primary chordae) into the LV outflow tract<sup><a href="#ref-114">114</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d93475e948>Conclusions</h2><p class="" id=d93475e951>The number of patients affected by cardiomyopathies is increasing. Given the strong genetic basis of many cardiomyopathies, a complete family history is mandatory. Judicious use of cardiac imaging is extremely useful in defining the morpho-functional phenotype, informing prognosis, and detecting subclinical disease. Genetic testing is being increasingly incorporated into clinical practice. MOGES classification provides a good framework to facilitate communication and patient classification. The use of patient-specific pluripotent stem cell-derived cardiomyocytes for disease modeling and therapeutic testing is exciting and hopefully will be incorporated into clinical practice in the near future. Gene therapy, small molecules, small interfering RNA, and antisense oligonucleotides are being tested in clinical trials.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d93475e1 class=n-a></a><h2 class=main-title id=d93849>Competing interests</h2><p class=metadata-entry><a name=d93475e98 class=n-a></a><p id=d93475e99> The authors declare that they have no competing interests.</p></p></div><div class=back-section><a name=d93475e1 class=n-a></a><h2 class=main-title id=d93851>Grant information</h2><p>WT is supported by grants from the National Institutes of Health (R01HL103866, P20HL113452, R01DK106000, and R01HL126827).</p><p> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </p></div><div class=back-section><a name=d93475e958 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d94243>References</h2><div class="section ref-list"><a name=d93475e958 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d93475e965 class=n-a></a>Arbustini E, Narula N, Tavazzi L, <i> et al.</i>: The MOGE(S) classification of cardiomyopathy for clinicians. <i>J Am Coll Cardiol.</i> 2014; <b>64</b>(3): 30418. <a target=xrefwindow id=d93475e976 href="http://www.ncbi.nlm.nih.gov/pubmed/25034069">PubMed Abstract </a> | <a target=xrefwindow id=d93475e979 href="http://dx.doi.org/10.1016/j.jacc.2014.05.027">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726023516"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e988 class=n-a></a>Writing Group Members, Mozaffarian D, Benjamin EJ, <i> et al.</i>: Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. <i>Circulation.</i> 2016; <b>133</b>(4): e38360. <a target=xrefwindow id=d93475e999 href="http://www.ncbi.nlm.nih.gov/pubmed/26673558">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1002 href="http://dx.doi.org/10.1161/CIR.0000000000000350">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726023516">F1000 Recommendation</a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d93475e1015 class=n-a></a>GBD 2015 Mortality and Causes of Death Collaborators: Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 19802015: a systematic analysis for the Global Burden of Disease Study 2015. <i>Lancet.</i> 2016; <b>388</b>(10053): 1459544. <a target=xrefwindow id=d93475e1023 href="http://www.ncbi.nlm.nih.gov/pubmed/27733281">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1026 href="http://dx.doi.org/10.1016/S0140-6736(16)31012-1">Publisher Full Text </a> | <a target=xrefwindow id=d93475e1029 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5388903">Free Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d93475e1038 class=n-a></a>Yusen RD, Edwards LB, Kucheryavaya AY, <i> et al.</i>: The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Lung and Heart-Lung Transplantation Report--2015; Focus Theme: Early Graft Failure. <i>J Heart Lung Transplant.</i> 2015; <b>34</b>(10): 126477. <a target=xrefwindow id=d93475e1049 href="http://www.ncbi.nlm.nih.gov/pubmed/26454740">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1052 href="http://dx.doi.org/10.1016/j.healun.2015.08.014">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726647503"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e1061 class=n-a></a>Manrai AK, Funke BH, Rehm HL, <i> et al.</i>: Genetic Misdiagnoses and the Potential for Health Disparities. <i>N Engl J Med.</i> 2016; <b>375</b>(7): 65565. <a target=xrefwindow id=d93475e1072 href="http://www.ncbi.nlm.nih.gov/pubmed/27532831">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1075 href="http://dx.doi.org/10.1056/NEJMsa1507092">Publisher Full Text </a> | <a target=xrefwindow id=d93475e1079 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5292722">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726647503">F1000 Recommendation</a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d93475e1093 class=n-a></a>Richardson P, McKenna W, Bristow M, <i> et al.</i>: Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. <i>Circulation.</i> 1996; <b>93</b>(5): 8412. <a target=xrefwindow id=d93475e1104 href="http://www.ncbi.nlm.nih.gov/pubmed/8598070">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1107 href="http://dx.doi.org/10.1161/01.CIR.93.5.841">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d93475e1116 class=n-a></a>Maron BJ, Towbin JA, Thiene G, <i> et al.</i>: Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. <i>Circulation.</i> 2006; <b>113</b>(14): 180716. <a target=xrefwindow id=d93475e1127 href="http://www.ncbi.nlm.nih.gov/pubmed/16567565">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1130 href="http://dx.doi.org/10.1161/CIRCULATIONAHA.106.174287">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d93475e1139 class=n-a></a>Elliott P, Andersson B, Arbustini E, <i> et al.</i>: Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. <i>Eur Heart J.</i> 2008; <b>29</b>(2): 2706. <a target=xrefwindow id=d93475e1150 href="http://www.ncbi.nlm.nih.gov/pubmed/17916581">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1153 href="http://dx.doi.org/10.1093/eurheartj/ehm342">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d93475e1162 class=n-a></a>Bozkurt B, Colvin M, Cook J, <i> et al.</i>: Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association. <i>Circulation.</i> 2016; <b>134</b>(23): e579e646. <a target=xrefwindow id=d93475e1173 href="http://www.ncbi.nlm.nih.gov/pubmed/27832612">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1176 href="http://dx.doi.org/10.1161/CIR.0000000000000455">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d93475e1185 class=n-a></a>Nagueh SF: Fabry disease. <i>Heart.</i> 2003; <b>89</b>(8): 81920. <a target=xrefwindow id=d93475e1193 href="http://www.ncbi.nlm.nih.gov/pubmed/12860841">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1196 href="http://dx.doi.org/10.1136/heart.89.8.819">Publisher Full Text </a> | <a target=xrefwindow id=d93475e1199 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1767779">Free Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d93475e1208 class=n-a></a>Weir-McCall JR, Yeap PM, Papagiorcopulo C, <i> et al.</i>: Left Ventricular Noncompaction: Anatomical Phenotype or Distinct Cardiomyopathy? <i>J Am Coll Cardiol.</i> 2016; <b>68</b>(20): 215765. <a target=xrefwindow id=d93475e1219 href="http://www.ncbi.nlm.nih.gov/pubmed/27855805">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1222 href="http://dx.doi.org/10.1016/j.jacc.2016.08.054">Publisher Full Text </a> | <a target=xrefwindow id=d93475e1226 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5116443">Free Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d93475e1236 class=n-a></a>Maron BJ, Maron MS: The 25-year genetic era in hypertrophic cardiomyopathy: revisited. <i>Circ Cardiovasc Genet.</i> 2014; <b>7</b>(4): 4014. <a target=xrefwindow id=d93475e1244 href="http://www.ncbi.nlm.nih.gov/pubmed/25140059">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1247 href="http://dx.doi.org/10.1161/CIRCGENETICS.114.000741">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726951966"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e1256 class=n-a></a>Quarta G, Papadakis M, Donna PD, <i> et al.</i>: Grey zones in cardiomyopathies: defining boundaries between genetic and iatrogenic disease. <i>Nat Rev Cardiol.</i> 2017; <b>14</b>(2): 10212. <a target=xrefwindow id=d93475e1267 href="http://www.ncbi.nlm.nih.gov/pubmed/27830773">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1270 href="http://dx.doi.org/10.1038/nrcardio.2016.175">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726951966">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d93475e1283 class=n-a></a>Sen-Chowdhry S, Jacoby D, Moon JC, <i> et al.</i>: Update on hypertrophic cardiomyopathy and a guide to the guidelines. <i>Nat Rev Cardiol.</i> 2016; <b>13</b>(11): 65175. <a target=xrefwindow id=d93475e1294 href="http://www.ncbi.nlm.nih.gov/pubmed/27681577">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1297 href="http://dx.doi.org/10.1038/nrcardio.2016.140">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d93475e1306 class=n-a></a>Sheikh N, Papadakis M, Schnell F, <i> et al.</i>: Clinical Profile of Athletes With Hypertrophic Cardiomyopathy. <i>Circ Cardiovasc Imaging.</i> 2015; <b>8</b>(7): e003454. <a target=xrefwindow id=d93475e1317 href="http://www.ncbi.nlm.nih.gov/pubmed/26198026">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1320 href="http://dx.doi.org/10.1161/CIRCIMAGING.114.003454">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727038208"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e1329 class=n-a></a>Narula S, Shameer K, Salem Omar AM, <i> et al.</i>: Machine-Learning Algorithms to Automate Morphological and Functional Assessments in 2D Echocardiography. <i>J Am Coll Cardiol.</i> 2016; <b>68</b>(21): 228795. <a target=xrefwindow id=d93475e1340 href="http://www.ncbi.nlm.nih.gov/pubmed/27884247">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1343 href="http://dx.doi.org/10.1016/j.jacc.2016.08.062">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727038208">F1000 Recommendation</a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725249997"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e1356 class=n-a></a>Joyce E, Ninaber MK, Katsanos S, <i> et al.</i>: Subclinical left ventricular dysfunction by echocardiographic speckle-tracking strain analysis relates to outcome in sarcoidosis. <i>Eur J Heart Fail.</i> 2015; <b>17</b>(1): 5162. <a target=xrefwindow id=d93475e1367 href="http://www.ncbi.nlm.nih.gov/pubmed/25431267">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1370 href="http://dx.doi.org/10.1002/ejhf.205">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725249997">F1000 Recommendation</a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d93475e1384 class=n-a></a>Plana JC, Galderisi M, Barac A, <i> et al.</i>: Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. <i>Eur Heart J Cardiovasc Imaging.</i> 2014; <b>15</b>(10): 106393. <a target=xrefwindow id=d93475e1395 href="http://www.ncbi.nlm.nih.gov/pubmed/25239940">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1398 href="http://dx.doi.org/10.1093/ehjci/jeu192">Publisher Full Text </a> | <a target=xrefwindow id=d93475e1402 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4402366">Free Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d93475e1411 class=n-a></a>Jan MF, Todaro MC, Oreto L, <i> et al.</i>: Apical hypertrophic cardiomyopathy: Present status. <i>Int J Cardiol.</i> 2016; <b>222</b>: 74559. <a target=xrefwindow id=d93475e1422 href="http://www.ncbi.nlm.nih.gov/pubmed/27521551">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1425 href="http://dx.doi.org/10.1016/j.ijcard.2016.07.154">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d93475e1434 class=n-a></a>Falk RH, Alexander KM, Liao R, <i> et al.</i>: AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy. <i>J Am Coll Cardiol.</i> 2016; <b>68</b>(12): 132341. <a target=xrefwindow id=d93475e1445 href="http://www.ncbi.nlm.nih.gov/pubmed/27634125">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1448 href="http://dx.doi.org/10.1016/j.jacc.2016.06.053">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d93475e1457 class=n-a></a>Dhillon A, Sweet W, Popovic ZB, <i> et al.</i>: Association of noninvasively measured left ventricular mechanics with <i>in vitro</i> muscle contractile performance: a prospective study in hypertrophic cardiomyopathy patients. <i>J Am Heart Assoc.</i> 2014; <b>3</b>(6): e001269. <a target=xrefwindow id=d93475e1471 href="http://www.ncbi.nlm.nih.gov/pubmed/25389286">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1475 href="http://dx.doi.org/10.1161/JAHA.114.001269">Publisher Full Text </a> | <a target=xrefwindow id=d93475e1478 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4338715">Free Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d93475e1487 class=n-a></a>Cordero-Reyes AM, Youker K, Estep JD, <i> et al.</i>: Molecular and cellular correlates of cardiac function in end-stage DCM: a study using speckle tracking echocardiography. <i>JACC Cardiovasc Imaging.</i> 2014; <b>7</b>(5): 44152. <a target=xrefwindow id=d93475e1498 href="http://www.ncbi.nlm.nih.gov/pubmed/24726255">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1501 href="http://dx.doi.org/10.1016/j.jcmg.2013.11.010">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d93475e1510 class=n-a></a>Ro R, Halpern D, Sahn DJ, <i> et al.</i>: Vector flow mapping in obstructive hypertrophic cardiomyopathy to assess the relationship of early systolic left ventricular flow and the mitral valve. <i>J Am Coll Cardiol.</i> 2014; <b>64</b>(19): 198495. <a target=xrefwindow id=d93475e1521 href="http://www.ncbi.nlm.nih.gov/pubmed/25440093">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1524 href="http://dx.doi.org/10.1016/j.jacc.2014.04.090">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d93475e1534 class=n-a></a>Maragiannis D, Alvarez PA, Schutt RC, <i> et al.</i>: Vortex Formation Time Index in Patients With Hypertrophic Cardiomyopathy. <i>JACC Cardiovasc Imaging.</i> 2016; <b>9</b>(10): 122931. <a target=xrefwindow id=d93475e1545 href="http://www.ncbi.nlm.nih.gov/pubmed/26684967">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1548 href="http://dx.doi.org/10.1016/j.jcmg.2015.10.009">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d93475e1557 class=n-a></a>Gruner C, Chan RH, Crean A, <i> et al.</i>: Significance of left ventricular apical-basal muscle bundle identified by cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy. <i>Eur Heart J.</i> 2014; <b>35</b>(39): 270613. <a target=xrefwindow id=d93475e1568 href="http://www.ncbi.nlm.nih.gov/pubmed/24810389">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1571 href="http://dx.doi.org/10.1093/eurheartj/ehu154">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/718240424"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e1580 class=n-a></a>Maron MS, Olivotto I, Harrigan C, <i> et al.</i>: Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy. <i>Circulation.</i> 2011; <b>124</b>(1): 407. <a target=xrefwindow id=d93475e1591 href="http://www.ncbi.nlm.nih.gov/pubmed/21670234">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1594 href="http://dx.doi.org/10.1161/CIRCULATIONAHA.110.985812">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/718240424">F1000 Recommendation</a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d93475e1607 class=n-a></a>Captur G, Lopes LR, Patel V, <i> et al.</i>: Abnormal cardiac formation in hypertrophic cardiomyopathy: fractal analysis of trabeculae and preclinical gene expression. <i>Circ Cardiovasc Genet.</i> 2014; <b>7</b>(3): 2418. <a target=xrefwindow id=d93475e1618 href="http://www.ncbi.nlm.nih.gov/pubmed/24704860">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1621 href="http://dx.doi.org/10.1161/CIRCGENETICS.113.000362">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/728080267"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e1630 class=n-a></a>Rastegar N, Zimmerman SL, Te Riele ASJM, <i> et al.</i>: Spectrum of Biventricular Involvement on CMR Among Carriers of ARVD/C-Associated Mutations. <i>JACC Cardiovasc Imaging.</i> 2015; <b>8</b>(7): 8634. <a target=xrefwindow id=d93475e1641 href="http://www.ncbi.nlm.nih.gov/pubmed/25457767">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1644 href="http://dx.doi.org/10.1016/j.jcmg.2014.09.009">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/728080267">F1000 Recommendation</a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d93475e1657 class=n-a></a>Calkins H, Tandri H: Left Ventricular Involvement in ARVD/C: Is It Time to Readjust Our Views? <i>Circ Arrhythm Electrophysiol.</i> 2015; <b>8</b>(6): 13112. <a target=xrefwindow id=d93475e1665 href="http://www.ncbi.nlm.nih.gov/pubmed/26671934">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1668 href="http://dx.doi.org/10.1161/CIRCEP.115.003534">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/727147940"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e1678 class=n-a></a>Di Marco A, Anguera I, Schmitt M, <i> et al.</i>: Late Gadolinium Enhancement and the Risk for Ventricular Arrhythmias or Sudden Death in Dilated Cardiomyopathy: Systematic Review and Meta-Analysis. <i>JACC Heart Fail.</i> 2017; <b>5</b>(1): 2838. <a target=xrefwindow id=d93475e1689 href="http://www.ncbi.nlm.nih.gov/pubmed/28017348">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1692 href="http://dx.doi.org/10.1016/j.jchf.2016.09.017">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/727147940">F1000 Recommendation</a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/718520673"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e1705 class=n-a></a>Chan RH, Maron BJ, Olivotto I, <i> et al.</i>: Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. <i>Circulation.</i> 2014; <b>130</b>(6): 48495. <a target=xrefwindow id=d93475e1716 href="http://www.ncbi.nlm.nih.gov/pubmed/25092278">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1719 href="http://dx.doi.org/10.1161/CIRCULATIONAHA.113.007094">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/718520673">F1000 Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/727265445"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e1732 class=n-a></a>Tandon A, Villa CR, Hor KN, <i> et al.</i>: Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in duchenne muscular dystrophy. <i>J Am Heart Assoc.</i> 2015; <b>4</b>(4): pii: e001338. <a target=xrefwindow id=d93475e1743 href="http://www.ncbi.nlm.nih.gov/pubmed/25814625">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1746 href="http://dx.doi.org/10.1161/JAHA.114.001338">Publisher Full Text </a> | <a target=xrefwindow id=d93475e1750 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4579941">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/727265445">F1000 Recommendation</a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d93475e1763 class=n-a></a>Maceira AM, Joshi J, Prasad SK, <i> et al.</i>: Cardiovascular magnetic resonance in cardiac amyloidosis. <i>Circulation.</i> 2005; <b>111</b>(2): 18693. <a target=xrefwindow id=d93475e1774 href="http://www.ncbi.nlm.nih.gov/pubmed/15630027">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1777 href="http://dx.doi.org/10.1161/01.CIR.0000152819.97857.9D">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d93475e1786 class=n-a></a>Karamitsos TD, Piechnik SK, Banypersad SM, <i> et al.</i>: Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. <i>JACC Cardiovasc Imaging.</i> 2013; <b>6</b>(4): 48897. <a target=xrefwindow id=d93475e1797 href="http://www.ncbi.nlm.nih.gov/pubmed/23498672">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1800 href="http://dx.doi.org/10.1016/j.jcmg.2012.11.013">Publisher Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d93475e1809 class=n-a></a>Collins J, Sommerville C, Magrath P, <i> et al.</i>: Extracellular volume fraction is more closely associated with altered regional left ventricular velocities than left ventricular ejection fraction in nonischemic cardiomyopathy. <i>Circ Cardiovasc Imaging.</i> 2014; <b>8</b>(1): pii: e001998. <a target=xrefwindow id=d93475e1820 href="http://www.ncbi.nlm.nih.gov/pubmed/25552491">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1823 href="http://dx.doi.org/10.1161/CIRCIMAGING.114.001998">Publisher Full Text </a> | <a target=xrefwindow id=d93475e1827 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4283574">Free Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d93475e1837 class=n-a></a>Fontana M, Barison A, Botto N, <i> et al.</i>: CMR-verified interstitial myocardial fibrosis as a marker of subclinical cardiac involvement in <i>LMNA</i> mutation carriers. <i>JACC Cardiovasc Imaging.</i> 2013; <b>6</b>(1): 1246. <a target=xrefwindow id=d93475e1851 href="http://www.ncbi.nlm.nih.gov/pubmed/23328570">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1855 href="http://dx.doi.org/10.1016/j.jcmg.2012.06.013">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/727301668"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e1864 class=n-a></a>Nielles-Vallespin S, Khalique Z, Ferreira PF, <i> et al.</i>: Assessment of Myocardial Microstructural Dynamics by <i>In Vivo</i> Diffusion Tensor Cardiac Magnetic Resonance. <i>J Am Coll Cardiol.</i> 2017; <b>69</b>(6): 66176. <a target=xrefwindow id=d93475e1878 href="http://www.ncbi.nlm.nih.gov/pubmed/28183509">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1882 href="http://dx.doi.org/10.1016/j.jacc.2016.11.051">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/727301668">F1000 Recommendation</a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d93475e1895 class=n-a></a>Allen BD, Choudhury L, Barker AJ, <i> et al.</i>: Three-dimensional haemodynamics in patients with obstructive and non-obstructive hypertrophic cardiomyopathy assessed by cardiac magnetic resonance. <i>Eur Heart J Cardiovasc Imaging.</i> 2015; <b>16</b>(1): 2936. <a target=xrefwindow id=d93475e1906 href="http://www.ncbi.nlm.nih.gov/pubmed/25108915">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1909 href="http://dx.doi.org/10.1093/ehjci/jeu146">Publisher Full Text </a> | <a target=xrefwindow id=d93475e1913 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4366608">Free Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d93475e1922 class=n-a></a>Blankstein R, Osborne M, Naya M, <i> et al.</i>: Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. <i>J Am Coll Cardiol.</i> 2014; <b>63</b>(4): 32936. <a target=xrefwindow id=d93475e1933 href="http://www.ncbi.nlm.nih.gov/pubmed/24140661">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1936 href="http://dx.doi.org/10.1016/j.jacc.2013.09.022">Publisher Full Text </a> | <a target=xrefwindow id=d93475e1940 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3955730">Free Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d93475e1949 class=n-a></a>Gertz MA, Dispenzieri A, Sher T: Pathophysiology and treatment of cardiac amyloidosis. <i>Nat Rev Cardiol.</i> 2015; <b>12</b>(12): 91102. <a target=xrefwindow id=d93475e1957 href="http://www.ncbi.nlm.nih.gov/pubmed/25311231">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1960 href="http://dx.doi.org/10.1038/nrcardio.2014.165">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d93475e1969 class=n-a></a>Witt CM, Eleid MF, Nishimura RA: Diagnosis of constrictive pericarditis obscured by hypertrophic cardiomyopathy: Back to basics. <i>Catheter Cardiovasc Interv.</i> 2015; <b>86</b>(3): 5369. <a target=xrefwindow id=d93475e1977 href="http://www.ncbi.nlm.nih.gov/pubmed/25639819">PubMed Abstract </a> | <a target=xrefwindow id=d93475e1980 href="http://dx.doi.org/10.1002/ccd.25873">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d93475e1990 class=n-a></a>From AM, Maleszewski JJ, Rihal CS: Current status of endomyocardial biopsy. <i>Mayo Clin Proc.</i> 2011; <b>86</b>(11): 1095102. <a target=xrefwindow id=d93475e1998 href="http://www.ncbi.nlm.nih.gov/pubmed/22033254">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2001 href="http://dx.doi.org/10.4065/mcp.2011.0296">Publisher Full Text </a> | <a target=xrefwindow id=d93475e2004 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3203000">Free Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d93475e2013 class=n-a></a>Felker GM, Thompson RE, Hare JM, <i> et al.</i>: Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. <i>N Engl J Med.</i> 2000; <b>342</b>(15): 107784. <a target=xrefwindow id=d93475e2024 href="http://www.ncbi.nlm.nih.gov/pubmed/10760308">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2027 href="http://dx.doi.org/10.1056/NEJM200004133421502">Publisher Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d93475e2036 class=n-a></a>Platts D, Brown M, Javorsky G, <i> et al.</i>: Comparison of fluoroscopic versus real-time three-dimensional transthoracic echocardiographic guidance of endomyocardial biopsies. <i>Eur J Echocardiogr.</i> 2010; <b>11</b>(7): 63743. <a target=xrefwindow id=d93475e2047 href="http://www.ncbi.nlm.nih.gov/pubmed/20335406">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2050 href="http://dx.doi.org/10.1093/ejechocard/jeq036">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d93475e2059 class=n-a></a>Shah KB, Inoue Y, Mehra MR: Amyloidosis and the heart: a comprehensive review. <i>Arch Intern Med.</i> 2006; <b>166</b>(17): 180513. <a target=xrefwindow id=d93475e2067 href="http://www.ncbi.nlm.nih.gov/pubmed/17000935">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2070 href="http://dx.doi.org/10.1001/archinte.166.17.1805">Publisher Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d93475e2079 class=n-a></a>Hulten E, Aslam S, Osborne M, <i> et al.</i>: Cardiac sarcoidosis-state of the art review. <i>Cardiovasc Diagn Ther.</i> 2016; <b>6</b>(1): 5063. <a target=xrefwindow id=d93475e2090 href="http://www.ncbi.nlm.nih.gov/pubmed/26885492">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2093 href="http://dx.doi.org/10.3978/j.issn.2223-3652.2015.12.13">Publisher Full Text </a> | <a target=xrefwindow id=d93475e2097 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4731586">Free Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d93475e2106 class=n-a></a>Chimenti C, Frustaci A: Contribution and risks of left ventricular endomyocardial biopsy in patients with cardiomyopathies: a retrospective study over a 28-year period. <i>Circulation.</i> 2013; <b>128</b>(14): 153141. <a target=xrefwindow id=d93475e2114 href="http://www.ncbi.nlm.nih.gov/pubmed/24004501">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2117 href="http://dx.doi.org/10.1161/CIRCULATIONAHA.13.001414">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d93475e2127 class=n-a></a>Liang JJ, Hebl VB, DeSimone CV, <i> et al.</i>: Electrogram guidance: a method to increase the precision and diagnostic yield of endomyocardial biopsy for suspected cardiac sarcoidosis and myocarditis. <i>JACC Heart Fail.</i> 2014; <b>2</b>(5): 46673. <a target=xrefwindow id=d93475e2138 href="http://www.ncbi.nlm.nih.gov/pubmed/25194292">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2141 href="http://dx.doi.org/10.1016/j.jchf.2014.03.015">Publisher Full Text </a> | <a target=xrefwindow id=d93475e2145 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4459501">Free Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d93475e2154 class=n-a></a>Dominguez F, Khl U, Pieske B, <i> et al.</i>: Update on Myocarditis and Inflammatory Cardiomyopathy: Reemergence of Endomyocardial Biopsy. <i>Rev Esp Cardiol (Engl Ed).</i> 2016; <b>69</b>(2): 17887. <a target=xrefwindow id=d93475e2165 href="http://www.ncbi.nlm.nih.gov/pubmed/26795929">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2168 href="http://dx.doi.org/10.1016/j.rec.2015.10.015">Publisher Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d93475e2177 class=n-a></a>Kuehl U, Lassner D, Gast M, <i> et al.</i>: Differential Cardiac MicroRNA Expression Predicts the Clinical Course in Human Enterovirus Cardiomyopathy. <i>Circ Heart Fail.</i> 2015; <b>8</b>(3): 60518. <a target=xrefwindow id=d93475e2188 href="http://www.ncbi.nlm.nih.gov/pubmed/25761932">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2191 href="http://dx.doi.org/10.1161/CIRCHEARTFAILURE.114.001475">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d93475e2200 class=n-a></a>Saito T, Asai K, Sato S, <i> et al.</i>: Ultrastructural features of cardiomyocytes in dilated cardiomyopathy with initially decompensated heart failure as a predictor of prognosis. <i>Eur Heart J.</i> 2015; <b>36</b>(12): 72432. <a target=xrefwindow id=d93475e2211 href="http://www.ncbi.nlm.nih.gov/pubmed/25336212">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2214 href="http://dx.doi.org/10.1093/eurheartj/ehu404">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d93475e2223 class=n-a></a>Yancy CW, Jessup M, Bozkurt B, <i> et al.</i>: 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. <i>J Am Coll Cardiol.</i> 2013; <b>62</b>(16): e147239. <a target=xrefwindow id=d93475e2234 href="http://www.ncbi.nlm.nih.gov/pubmed/23747642">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2237 href="http://dx.doi.org/10.1016/j.jacc.2013.05.019">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/718240410"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e2246 class=n-a></a>Gersh BJ, Maron BJ, Bonow RO, <i> et al.</i>: 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. <i>J Am Coll Cardiol.</i> 2011; <b>58</b>(25): e21260. <a target=xrefwindow id=d93475e2257 href="http://www.ncbi.nlm.nih.gov/pubmed/22075469">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2260 href="http://dx.doi.org/10.1016/j.jacc.2011.06.011">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/718240410">F1000 Recommendation</a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d93475e2274 class=n-a></a>Birnie DH, Sauer WH, Bogun F, <i> et al.</i>: HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. <i>Heart Rhythm.</i> 2014; <b>11</b>(7): 130523. <a target=xrefwindow id=d93475e2285 href="http://www.ncbi.nlm.nih.gov/pubmed/24819193">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2288 href="http://dx.doi.org/10.1016/j.hrthm.2014.03.043">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d93475e2297 class=n-a></a>Daubert C, Behar N, Martins RP, <i> et al.</i>: Avoiding non-responders to cardiac resynchronization therapy: a practical guide. <i>Eur Heart J.</i> 2017; <b>38</b>(19): 146372. <a target=xrefwindow id=d93475e2308 href="http://www.ncbi.nlm.nih.gov/pubmed/27371720">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2311 href="http://dx.doi.org/10.1093/eurheartj/ehw270">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d93475e2320 class=n-a></a>Kirk JA, Chakir K, Lee KH, <i> et al.</i>: Pacemaker-induced transient asynchrony suppresses heart failure progression. <i>Sci Transl Med.</i> 2015; <b>7</b>(319): 319ra207. <a target=xrefwindow id=d93475e2331 href="http://www.ncbi.nlm.nih.gov/pubmed/26702095">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2334 href="http://dx.doi.org/10.1126/scitranslmed.aad2899">Publisher Full Text </a> | <a target=xrefwindow id=d93475e2338 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4858435">Free Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d93475e2347 class=n-a></a>Latchamsetty R, Bogun F: Premature Ventricular Complex-induced Cardiomyopathy. <i>Rev Esp Cardiol (Engl Ed).</i> 2016; <b>69</b>(4): 3659. <a target=xrefwindow id=d93475e2355 href="http://www.ncbi.nlm.nih.gov/pubmed/26935453">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2358 href="http://dx.doi.org/10.1016/j.rec.2015.12.015">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/727280583"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e2367 class=n-a></a>Venlet J, Piers SR, Jongbloed JD, <i> et al.</i>: Isolated Subepicardial Right Ventricular Outflow Tract Scar in Athletes With Ventricular Tachycardia. <i>J Am Coll Cardiol.</i> 2017; <b>69</b>(5): 497507. <a target=xrefwindow id=d93475e2378 href="http://www.ncbi.nlm.nih.gov/pubmed/28153106">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2381 href="http://dx.doi.org/10.1016/j.jacc.2016.11.041">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/727280583">F1000 Recommendation</a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d93475e2394 class=n-a></a>Burke MA, Cook SA, Seidman JG, <i> et al.</i>: Clinical and Mechanistic Insights Into the Genetics of Cardiomyopathy. <i>J Am Coll Cardiol.</i> 2016; <b>68</b>(25): 287186. <a target=xrefwindow id=d93475e2405 href="http://www.ncbi.nlm.nih.gov/pubmed/28007147">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2408 href="http://dx.doi.org/10.1016/j.jacc.2016.08.079">Publisher Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/13914956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e2418 class=n-a></a>Herman DS, Lam L, Taylor MR, <i> et al.</i>: Truncations of titin causing dilated cardiomyopathy. <i>N Engl J Med.</i> 2012; <b>366</b>(7): 61928. <a target=xrefwindow id=d93475e2429 href="http://www.ncbi.nlm.nih.gov/pubmed/22335739">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2432 href="http://dx.doi.org/10.1056/NEJMoa1110186">Publisher Full Text </a> | <a target=xrefwindow id=d93475e2436 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3660031">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/13914956">F1000 Recommendation</a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d93475e2449 class=n-a></a>Coppini R, Ho CY, Ashley E, <i> et al.</i>: Clinical phenotype and outcome of hypertrophic cardiomyopathy associated with thin-filament gene mutations. <i>J Am Coll Cardiol.</i> 2014; <b>64</b>(24): 2589600. <a target=xrefwindow id=d93475e2460 href="http://www.ncbi.nlm.nih.gov/pubmed/25524337">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2463 href="http://dx.doi.org/10.1016/j.jacc.2014.09.059">Publisher Full Text </a> | <a target=xrefwindow id=d93475e2467 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4270453">Free Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d93475e2476 class=n-a></a>Brun F, Barnes CV, Sinagra G, <i> et al.</i>: Titin and desmosomal genes in the natural history of arrhythmogenic right ventricular cardiomyopathy. <i>J Med Genet.</i> 2014; <b>51</b>(10): 66976. <a target=xrefwindow id=d93475e2487 href="http://www.ncbi.nlm.nih.gov/pubmed/25157032">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2490 href="http://dx.doi.org/10.1136/jmedgenet-2014-102591">Publisher Full Text </a> | <a target=xrefwindow id=d93475e2494 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4465780">Free Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d93475e2503 class=n-a></a>Bhonsale A, Groeneweg JA, James CA, <i> et al.</i>: Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers. <i>Eur Heart J.</i> 2015; <b>36</b>(14): 84755. <a target=xrefwindow id=d93475e2514 href="http://www.ncbi.nlm.nih.gov/pubmed/25616645">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2517 href="http://dx.doi.org/10.1093/eurheartj/ehu509">Publisher Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726781870"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e2526 class=n-a></a>Mital S, Musunuru K, Garg V, <i> et al.</i>: Enhancing Literacy in Cardiovascular Genetics: A Scientific Statement From the American Heart Association. <i>Circ Cardiovasc Genet.</i> 2016; <b>9</b>(5): 44867. <a target=xrefwindow id=d93475e2537 href="http://www.ncbi.nlm.nih.gov/pubmed/27672144">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2540 href="http://dx.doi.org/10.1161/HCG.0000000000000031">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726781870">F1000 Recommendation</a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d93475e2553 class=n-a></a>Alfares AA, Kelly MA, McDermott G, <i> et al.</i>: Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity. <i>Genet Med.</i> 2015; <b>17</b>(11): 8808. <a target=xrefwindow id=d93475e2564 href="http://www.ncbi.nlm.nih.gov/pubmed/25611685">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2567 href="http://dx.doi.org/10.1038/gim.2014.205">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d93475e2577 class=n-a></a>Parikh VN, Ashley EA: Next-Generation Sequencing in Cardiovascular Disease: Present Clinical Applications and the Horizon of Precision Medicine. <i>Circulation.</i> 2017; <b>135</b>(5): 4069. <a target=xrefwindow id=d93475e2585 href="http://www.ncbi.nlm.nih.gov/pubmed/28137961">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2588 href="http://dx.doi.org/10.1161/CIRCULATIONAHA.116.024258">Publisher Full Text </a> | <a target=xrefwindow id=d93475e2591 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5310819">Free Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726741600"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e2600 class=n-a></a>Hastings R, de Villiers CP, Hooper C, <i> et al.</i>: Combination of Whole Genome Sequencing, Linkage, and Functional Studies Implicates a Missense Mutation in Titin as a Cause of Autosomal Dominant Cardiomyopathy With Features of Left Ventricular Noncompaction. <i>Circ Cardiovasc Genet.</i> 2016; <b>9</b>(5): 42635. <a target=xrefwindow id=d93475e2611 href="http://www.ncbi.nlm.nih.gov/pubmed/27625337">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2614 href="http://dx.doi.org/10.1161/CIRCGENETICS.116.001431">Publisher Full Text </a> | <a target=xrefwindow id=d93475e2618 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5068189">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726741600">F1000 Recommendation</a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d93475e2631 class=n-a></a>Haas J, Frese KS, Peil B, <i> et al.</i>: Atlas of the clinical genetics of human dilated cardiomyopathy. <i>Eur Heart J.</i> 2015; <b>36</b>(18): 112335a. <a target=xrefwindow id=d93475e2642 href="http://www.ncbi.nlm.nih.gov/pubmed/25163546">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2645 href="http://dx.doi.org/10.1093/eurheartj/ehu301">Publisher Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725289267"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e2654 class=n-a></a>Quarta CC, Buxbaum JN, Shah AM, <i> et al.</i>: The amyloidogenic V122I transthyretin variant in elderly black Americans. <i>N Engl J Med.</i> 2015; <b>372</b>(1): 219. <a target=xrefwindow id=d93475e2665 href="http://www.ncbi.nlm.nih.gov/pubmed/25551524">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2668 href="http://dx.doi.org/10.1056/NEJMoa1404852">Publisher Full Text </a> | <a target=xrefwindow id=d93475e2672 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4382209">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725289267">F1000 Recommendation</a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d93475e2685 class=n-a></a>Sperry BW, Tang WHW: Amyloid heart disease: genetics translated into disease-modifying therapy. <i>Heart.</i> 2017; <b>103</b>(11): 8127. <a target=xrefwindow id=d93475e2693 href="http://www.ncbi.nlm.nih.gov/pubmed/28255101">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2696 href="http://dx.doi.org/10.1136/heartjnl-2016-309914">Publisher Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725332633"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e2705 class=n-a></a>Collins FS, Varmus H: A new initiative on precision medicine. <i>N Engl J Med.</i> 2015; <b>372</b>(9): 7935. <a target=xrefwindow id=d93475e2713 href="http://www.ncbi.nlm.nih.gov/pubmed/25635347">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2716 href="http://dx.doi.org/10.1056/NEJMp1500523">Publisher Full Text </a> | <a target=xrefwindow id=d93475e2719 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5101938">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725332633">F1000 Recommendation</a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d93475e2733 class=n-a></a>Takahashi K, Yamanaka S: A decade of transcription factor-mediated reprogramming to pluripotency. <i>Nat Rev Mol Cell Biol.</i> 2016; <b>17</b>(3): 18393. <a target=xrefwindow id=d93475e2741 href="http://www.ncbi.nlm.nih.gov/pubmed/26883003">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2744 href="http://dx.doi.org/10.1038/nrm.2016.8">Publisher Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d93475e2753 class=n-a></a>Burridge PW, Diecke S, Matsa E, <i> et al.</i>: Modeling Cardiovascular Diseases with Patient-Specific Human Pluripotent Stem Cell-Derived Cardiomyocytes. <i>Methods Mol Biol.</i> 2016; <b>1353</b>: 11930. <a target=xrefwindow id=d93475e2764 href="http://www.ncbi.nlm.nih.gov/pubmed/25690476">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2767 href="http://dx.doi.org/10.1007/7651_2015_196">Publisher Full Text </a> | <a target=xrefwindow id=d93475e2771 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4962608">Free Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d93475e2780 class=n-a></a>Sayed N, Liu C, Wu JC: Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine. <i>J Am Coll Cardiol.</i> 2016; <b>67</b>(18): 216176. <a target=xrefwindow id=d93475e2788 href="http://www.ncbi.nlm.nih.gov/pubmed/27151349">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2791 href="http://dx.doi.org/10.1016/j.jacc.2016.01.083">Publisher Full Text </a> | <a target=xrefwindow id=d93475e2794 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5086255">Free Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726755919"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e2803 class=n-a></a>Kodo K, Ong SG, Jahanbani F, <i> et al.</i>: iPSC-derived cardiomyocytes reveal abnormal TGF- signalling in left ventricular non-compaction cardiomyopathy. <i>Nat Cell Biol.</i> 2016; <b>18</b>(10): 103142. <a target=xrefwindow id=d93475e2814 href="http://www.ncbi.nlm.nih.gov/pubmed/27642787">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2817 href="http://dx.doi.org/10.1038/ncb3411">Publisher Full Text </a> | <a target=xrefwindow id=d93475e2821 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5042877">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726755919">F1000 Recommendation</a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d93475e2834 class=n-a></a>Hinson JT, Chopra A, Nafissi N, <i> et al.</i>: HEART DISEASE. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy. <i>Science.</i> 2015; <b>349</b>(6251): 9826. <a target=xrefwindow id=d93475e2845 href="http://www.ncbi.nlm.nih.gov/pubmed/26315439">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2848 href="http://dx.doi.org/10.1126/science.aaa5458">Publisher Full Text </a> | <a target=xrefwindow id=d93475e2852 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4618316">Free Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726293288"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e2861 class=n-a></a>Burridge PW, Li YF, Matsa E, <i> et al.</i>: Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity. <i>Nat Med.</i> 2016; <b>22</b>(5): 54756. <a target=xrefwindow id=d93475e2872 href="http://www.ncbi.nlm.nih.gov/pubmed/27089514">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2875 href="http://dx.doi.org/10.1038/nm.4087">Publisher Full Text </a> | <a target=xrefwindow id=d93475e2879 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5086256">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726293288">F1000 Recommendation</a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725357974"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e2893 class=n-a></a>Cannon L, Yu ZY, Marciniec T, <i> et al.</i>: Irreversible triggers for hypertrophic cardiomyopathy are established in the early postnatal period. <i>J Am Coll Cardiol.</i> 2015; <b>65</b>(6): 5609. <a target=xrefwindow id=d93475e2904 href="http://www.ncbi.nlm.nih.gov/pubmed/25677315">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2907 href="http://dx.doi.org/10.1016/j.jacc.2014.10.069">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725357974">F1000 Recommendation</a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725350719"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e2920 class=n-a></a>Ho CY, Lakdawala NK, Cirino AL, <i> et al.</i>: Diltiazem treatment for pre-clinical hypertrophic cardiomyopathy sarcomere mutation carriers: a pilot randomized trial to modify disease expression. <i>JACC Heart Fail.</i> 2015; <b>3</b>(2): 1808. <a target=xrefwindow id=d93475e2931 href="http://www.ncbi.nlm.nih.gov/pubmed/25543971">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2934 href="http://dx.doi.org/10.1016/j.jchf.2014.08.003">Publisher Full Text </a> | <a target=xrefwindow id=d93475e2938 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4323670">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725350719">F1000 Recommendation</a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725302226"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e2951 class=n-a></a>Axelsson A, Iversen K, Vejlstrup N, <i> et al.</i>: Efficacy and safety of the angiotensin II receptor blocker losartan for hypertrophic cardiomyopathy: the INHERIT randomised, double-blind, placebo-controlled trial. <i>Lancet Diabetes Endocrinol.</i> 2015; <b>3</b>(2): 12331. <a target=xrefwindow id=d93475e2962 href="http://www.ncbi.nlm.nih.gov/pubmed/25533774">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2965 href="http://dx.doi.org/10.1016/S2213-8587(14)70241-4">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725302226">F1000 Recommendation</a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d93475e2978 class=n-a></a>Cooper RM, Stables RH: Can RAS inhibitors affect the course of hypertrophic cardiomyopathy? <i>Lancet Diabetes Endocrinol.</i> 2015; <b>3</b>(2): 956. <a target=xrefwindow id=d93475e2986 href="http://www.ncbi.nlm.nih.gov/pubmed/25533773">PubMed Abstract </a> | <a target=xrefwindow id=d93475e2989 href="http://dx.doi.org/10.1016/S2213-8587(14)70253-0">Publisher Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727268415"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e2998 class=n-a></a>Silva MC, Magalhes TA, Meira ZM, <i> et al.</i>: Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy: A Randomized Clinical Trial. <i>JAMA Cardiol.</i> 2017; <b>2</b>(2): 1909. <a target=xrefwindow id=d93475e3009 href="http://www.ncbi.nlm.nih.gov/pubmed/27926769">PubMed Abstract </a> | <a target=xrefwindow id=d93475e3012 href="http://dx.doi.org/10.1001/jamacardio.2016.4801">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727268415">F1000 Recommendation</a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725296619"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e3025 class=n-a></a>Raman SV, Hor KN, Mazur W, <i> et al.</i>: Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial. <i>Lancet Neurol.</i> 2015; <b>14</b>(2): 15361. <a target=xrefwindow id=d93475e3036 href="http://www.ncbi.nlm.nih.gov/pubmed/25554404">PubMed Abstract </a> | <a target=xrefwindow id=d93475e3039 href="http://dx.doi.org/10.1016/S1474-4422(14)70318-7">Publisher Full Text </a> | <a target=xrefwindow id=d93475e3043 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4361281">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725296619">F1000 Recommendation</a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727416438"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e3057 class=n-a></a>Saberi S, Wheeler M, Bragg-Gresham J, <i> et al.</i>: Effect of Moderate-Intensity Exercise Training on Peak Oxygen Consumption in Patients With Hypertrophic Cardiomyopathy: A Randomized Clinical Trial. <i>JAMA.</i> 2017; <b>317</b>(13): 134957. <a target=xrefwindow id=d93475e3068 href="http://www.ncbi.nlm.nih.gov/pubmed/28306757">PubMed Abstract </a> | <a target=xrefwindow id=d93475e3071 href="http://dx.doi.org/10.1001/jama.2017.2503">Publisher Full Text </a> | <a target=xrefwindow id=d93475e3075 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5469299">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727416438">F1000 Recommendation</a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/729069237"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e3088 class=n-a></a>Legallois D, Belin A, Nesterov SV, <i> et al.</i>: Cardiac rehabilitation improves coronary endothelial function in patients with heart failure due to dilated cardiomyopathy: A positron emission tomography study. <i>Eur J Prev Cardiol.</i> 2016; <b>23</b>(2): 12936. <a target=xrefwindow id=d93475e3099 href="http://www.ncbi.nlm.nih.gov/pubmed/25525058">PubMed Abstract </a> | <a target=xrefwindow id=d93475e3102 href="http://dx.doi.org/10.1177/2047487314565739">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/729069237">F1000 Recommendation</a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726171812"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e3115 class=n-a></a>Green EM, Wakimoto H, Anderson RL, <i> et al.</i>: A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice. <i>Science.</i> 2016; <b>351</b>(6273): 61721. <a target=xrefwindow id=d93475e3126 href="http://www.ncbi.nlm.nih.gov/pubmed/26912705">PubMed Abstract </a> | <a target=xrefwindow id=d93475e3129 href="http://dx.doi.org/10.1126/science.aad3456">Publisher Full Text </a> | <a target=xrefwindow id=d93475e3133 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4784435">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726171812">F1000 Recommendation</a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d93475e3146 class=n-a></a>Stern JA, Markova S, Ueda Y, <i> et al.</i>: A Small Molecule Inhibitor of Sarcomere Contractility Acutely Relieves Left Ventricular Outflow Tract Obstruction in Feline Hypertrophic Cardiomyopathy. <i>PLoS One.</i> 2016; <b>11</b>(12): e0168407. <a target=xrefwindow id=d93475e3157 href="http://www.ncbi.nlm.nih.gov/pubmed/27973580">PubMed Abstract </a> | <a target=xrefwindow id=d93475e3160 href="http://dx.doi.org/10.1371/journal.pone.0168407">Publisher Full Text </a> | <a target=xrefwindow id=d93475e3164 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5156432">Free Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d93475e3173 class=n-a></a>Maron M, Ashley E, Blok T, <i> et al.</i>: Abstract 16842: Obstructive Hypertrophic Cardiomyopathy: Initial Single Ascending Dose Data in Healthy Volunteers and Patients. <i>Circulation.</i> 2016; <b>134</b>(Suppl 1): A16842. <a target=xrefwindow id=d93475e3184 href="http://circ.ahajournals.org/content/134/Suppl_1/A16842">Reference Source</a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727141053"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e3193 class=n-a></a>Yi JS, Huang Y, Kwaczala AT, <i> et al.</i>: Low-dose dasatinib rescues cardiac function in Noonan syndrome. <i>JCI Insight.</i> 2016; <b>1</b>(20): e90220. <a target=xrefwindow id=d93475e3204 href="http://www.ncbi.nlm.nih.gov/pubmed/27942593">PubMed Abstract </a> | <a target=xrefwindow id=d93475e3207 href="http://dx.doi.org/10.1172/jci.insight.90220">Publisher Full Text </a> | <a target=xrefwindow id=d93475e3211 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5135272">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727141053">F1000 Recommendation</a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a name=d93475e3225 class=n-a></a>Brayson D, Shanahan CM: Current insights into <i>LMNA</i> cardiomyopathies: Existing models and missing LINCs. <i>Nucleus.</i> 2017; <b>8</b>(1): 1733. <a target=xrefwindow id=d93475e3236 href="http://www.ncbi.nlm.nih.gov/pubmed/28125396">PubMed Abstract </a> | <a target=xrefwindow id=d93475e3239 href="http://dx.doi.org/10.1080/19491034.2016.1260798">Publisher Full Text </a> | <a target=xrefwindow id=d93475e3243 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5287098">Free Full Text </a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a name=d93475e3252 class=n-a></a>Brodsky GL, Muntoni F, Miocic S, <i> et al.</i>: Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. <i>Circulation.</i> 2000; <b>101</b>(5): 4736. <a target=xrefwindow id=d93475e3263 href="http://www.ncbi.nlm.nih.gov/pubmed/10662742">PubMed Abstract </a> | <a target=xrefwindow id=d93475e3266 href="http://dx.doi.org/10.1161/01.CIR.101.5.473">Publisher Full Text </a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a name=d93475e3275 class=n-a></a>Lanzicher T, Martinelli V, Puzzi L, <i> et al.</i>: The Cardiomyopathy Lamin A/C D192G Mutation Disrupts Whole-Cell Biomechanics in Cardiomyocytes as Measured by Atomic Force Microscopy Loading-Unloading Curve Analysis. <i>Sci Rep.</i> 2015; <b>5</b>: 13388. <a target=xrefwindow id=d93475e3286 href="http://www.ncbi.nlm.nih.gov/pubmed/26323789">PubMed Abstract </a> | <a target=xrefwindow id=d93475e3289 href="http://dx.doi.org/10.1038/srep13388">Publisher Full Text </a> | <a target=xrefwindow id=d93475e3293 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4555041">Free Full Text </a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d93475e3302 class=n-a></a>Davies BS, Barnes RH 2nd, Tu Y, <i> et al.</i>: An accumulation of non-farnesylated prelamin A causes cardiomyopathy but not progeria. <i>Hum Mol Genet.</i> 2010; <b>19</b>(13): 268294. <a target=xrefwindow id=d93475e3313 href="http://www.ncbi.nlm.nih.gov/pubmed/20421363">PubMed Abstract </a> | <a target=xrefwindow id=d93475e3316 href="http://dx.doi.org/10.1093/hmg/ddq158">Publisher Full Text </a> | <a target=xrefwindow id=d93475e3320 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2883346">Free Full Text </a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a name=d93475e3329 class=n-a></a>Lee JM, Nobumori C, Tu Y, <i> et al.</i>: Modulation of <i>LMNA</i> splicing as a strategy to treat prelamin A diseases. <i>J Clin Invest.</i> 2016; <b>126</b>(4): 1592602. <a target=xrefwindow id=d93475e3343 href="http://www.ncbi.nlm.nih.gov/pubmed/26999604">PubMed Abstract </a> | <a target=xrefwindow id=d93475e3347 href="http://dx.doi.org/10.1172/JCI85908">Publisher Full Text </a> | <a target=xrefwindow id=d93475e3350 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4811112">Free Full Text </a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a name=d93475e3359 class=n-a></a>Wu W, Muchir A, Shan J, <i> et al.</i>: Mitogen-activated protein kinase inhibitors improve heart function and prevent fibrosis in cardiomyopathy caused by mutation in lamin A/C gene. <i>Circulation.</i> 2011; <b>123</b>(1): 5361. <a target=xrefwindow id=d93475e3370 href="http://www.ncbi.nlm.nih.gov/pubmed/21173351">PubMed Abstract </a> | <a target=xrefwindow id=d93475e3373 href="http://dx.doi.org/10.1161/CIRCULATIONAHA.110.970673">Publisher Full Text </a> | <a target=xrefwindow id=d93475e3377 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3061281">Free Full Text </a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a name=d93475e3387 class=n-a></a>Choi JC, Muchir A, Wu W, <i> et al.</i>: Temsirolimus activates autophagy and ameliorates cardiomyopathy caused by lamin A/C gene mutation. <i>Sci Transl Med.</i> 2012; <b>4</b>(144): 144ra102. <a target=xrefwindow id=d93475e3398 href="http://www.ncbi.nlm.nih.gov/pubmed/22837537">PubMed Abstract </a> | <a target=xrefwindow id=d93475e3401 href="http://dx.doi.org/10.1126/scitranslmed.3003875">Publisher Full Text </a> | <a target=xrefwindow id=d93475e3405 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3700376">Free Full Text </a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a name=d93475e3414 class=n-a></a>Koyama M, Yano T, Kikuchi K, <i> et al.</i>: Everolimus-responsive dilated cardiomyopathy in tuberous sclerosis. <i>Eur Heart J.</i> 2015; <b>36</b>(34): 2338. <a target=xrefwindow id=d93475e3425 href="http://www.ncbi.nlm.nih.gov/pubmed/25636744">PubMed Abstract </a> | <a target=xrefwindow id=d93475e3428 href="http://dx.doi.org/10.1093/eurheartj/ehu526">Publisher Full Text </a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a name=d93475e3437 class=n-a></a>Hajjar RJ: Potential of gene therapy as a treatment for heart failure. <i>J Clin Invest.</i> 2013; <b>123</b>(1): 5361. <a target=xrefwindow id=d93475e3445 href="http://www.ncbi.nlm.nih.gov/pubmed/23281410">PubMed Abstract </a> | <a target=xrefwindow id=d93475e3448 href="http://dx.doi.org/10.1172/JCI62837">Publisher Full Text </a> | <a target=xrefwindow id=d93475e3451 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3533270">Free Full Text </a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a name=d93475e3460 class=n-a></a>Hulot J, Ishikawa K, Hajjar RJ: Gene therapy for the treatment of heart failure: promise postponed. <i>Eur Heart J.</i> 2016; <b>37</b>(21): 16518. <a target=xrefwindow id=d93475e3468 href="http://www.ncbi.nlm.nih.gov/pubmed/26922809">PubMed Abstract </a> | <a target=xrefwindow id=d93475e3471 href="http://dx.doi.org/10.1093/eurheartj/ehw019">Publisher Full Text </a> | <a target=xrefwindow id=d93475e3474 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4887702">Free Full Text </a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726098724"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e3483 class=n-a></a>Greenberg B, Butler J, Felker GM, <i> et al.</i>: Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial. <i>Lancet.</i> 2016; <b>387</b>(10024): 117886. <a target=xrefwindow id=d93475e3494 href="http://www.ncbi.nlm.nih.gov/pubmed/26803443">PubMed Abstract </a> | <a target=xrefwindow id=d93475e3497 href="http://dx.doi.org/10.1016/S0140-6736(16)00082-9">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726098724">F1000 Recommendation</a></span></li><li><a name=ref-101 class=n-a></a><span class=label>101. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726576233"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e3510 class=n-a></a>Hammond HK, Penny WF, Traverse JH, <i> et al.</i>: Intracoronary Gene Transfer of Adenylyl Cyclase 6 in Patients With Heart Failure: A Randomized Clinical Trial. <i>JAMA Cardiol.</i> 2016; <b>1</b>(2): 16371. <a target=xrefwindow id=d93475e3521 href="http://www.ncbi.nlm.nih.gov/pubmed/27437887">PubMed Abstract </a> | <a target=xrefwindow id=d93475e3524 href="http://dx.doi.org/10.1001/jamacardio.2016.0008">Publisher Full Text </a> | <a target=xrefwindow id=d93475e3528 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5535743">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726576233">F1000 Recommendation</a></span></li><li><a name=ref-102 class=n-a></a><span class=label>102. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726994958"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e3543 class=n-a></a>Butler J, Epstein SE, Greene SJ, <i> et al.</i>: Intravenous Allogeneic Mesenchymal Stem Cells for Nonischemic Cardiomyopathy: Safety and Efficacy Results of a Phase II-A Randomized Trial. <i>Circ Res.</i> 2017; <b>120</b>(2): 33240. <a target=xrefwindow id=d93475e3554 href="http://www.ncbi.nlm.nih.gov/pubmed/27856497">PubMed Abstract </a> | <a target=xrefwindow id=d93475e3557 href="http://dx.doi.org/10.1161/CIRCRESAHA.116.309717">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726994958">F1000 Recommendation</a></span></li><li><a name=ref-103 class=n-a></a><span class=label>103. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726994706"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e3570 class=n-a></a>Hare JM, DiFede DL, Rieger AC, <i> et al.</i>: Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial. <i>J Am Coll Cardiol.</i> 2017; <b>69</b>(5): 52637. <a target=xrefwindow id=d93475e3581 href="http://www.ncbi.nlm.nih.gov/pubmed/27856208">PubMed Abstract </a> | <a target=xrefwindow id=d93475e3584 href="http://dx.doi.org/10.1016/j.jacc.2016.11.009">Publisher Full Text </a> | <a target=xrefwindow id=d93475e3588 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5291766">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726994706">F1000 Recommendation</a></span></li><li><a name=ref-104 class=n-a></a><span class=label>104. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727484918"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e3601 class=n-a></a>Miyagawa S, Domae K, Yoshikawa Y, <i> et al.</i>: Phase I Clinical Trial of Autologous Stem Cell-Sheet Transplantation Therapy for Treating Cardiomyopathy. <i>J Am Heart Assoc.</i> 2017; <b>6</b>(4): pii: e003918. <a target=xrefwindow id=d93475e3612 href="http://www.ncbi.nlm.nih.gov/pubmed/28381469">PubMed Abstract </a> | <a target=xrefwindow id=d93475e3615 href="http://dx.doi.org/10.1161/JAHA.116.003918">Publisher Full Text </a> | <a target=xrefwindow id=d93475e3619 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5532985">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727484918">F1000 Recommendation</a></span></li><li><a name=ref-105 class=n-a></a><span class=label>105. </span>&nbsp;<span class=citation><a name=d93475e3632 class=n-a></a>Langer AL, Miao S, Mapara M, <i> et al.</i>: Results of Phase I Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients with AL Amyloidosis. <i>Blood.</i> 2015; <b>126</b>(23): 188. <a target=xrefwindow id=d93475e3643 href="http://www.bloodjournal.org/content/126/23/188">Reference Source</a></span></li><li><a name=ref-106 class=n-a></a><span class=label>106. </span>&nbsp;<span class=citation><a name=d93475e3652 class=n-a></a>Anker SD, von Haehling S: Inflammatory mediators in chronic heart failure: an overview. <i>Heart.</i> 2004; <b>90</b>(4): 46470. <a target=xrefwindow id=d93475e3660 href="http://www.ncbi.nlm.nih.gov/pubmed/15020532">PubMed Abstract </a> | <a target=xrefwindow id=d93475e3663 href="http://dx.doi.org/10.1136/hrt.2002.007005">Publisher Full Text </a> | <a target=xrefwindow id=d93475e3666 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1768165">Free Full Text </a></span></li><li><a name=ref-107 class=n-a></a><span class=label>107. </span>&nbsp;<span class=citation><a name=d93475e3675 class=n-a></a>Anker SD, Coats AJ: How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH. <i>Int J Cardiol.</i> 2002; <b>86</b>(23): 12330. <a target=xrefwindow id=d93475e3683 href="http://www.ncbi.nlm.nih.gov/pubmed/12419548">PubMed Abstract </a> | <a target=xrefwindow id=d93475e3686 href="http://dx.doi.org/10.1016/S0167-5273(02)00470-9">Publisher Full Text </a></span></li><li><a name=ref-108 class=n-a></a><span class=label>108. </span>&nbsp;<span class=citation><a name=d93475e3696 class=n-a></a>Torre-Amione G, Bourge RC, Colucci WS, <i> et al.</i>: A study to assess the effects of a broad-spectrum immune modulatory therapy on mortality and morbidity in patients with chronic heart failure: the ACCLAIM trial rationale and design. <i>Can J Cardiol.</i> 2007; <b>23</b>(5): 36976. <a target=xrefwindow id=d93475e3707 href="http://www.ncbi.nlm.nih.gov/pubmed/17440642">PubMed Abstract </a> | <a target=xrefwindow id=d93475e3710 href="http://dx.doi.org/10.1016/S0828-282X(07)70770-5">Publisher Full Text </a> | <a target=xrefwindow id=d93475e3714 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2649187">Free Full Text </a></span></li><li><a name=ref-109 class=n-a></a><span class=label>109. </span>&nbsp;<span class=citation><a name=d93475e3723 class=n-a></a>Mann DL: Innate immunity and the failing heart: the cytokine hypothesis revisited. <i>Circ Res.</i> 2015; <b>116</b>(7): 125468. <a target=xrefwindow id=d93475e3731 href="http://www.ncbi.nlm.nih.gov/pubmed/25814686">PubMed Abstract </a> | <a target=xrefwindow id=d93475e3734 href="http://dx.doi.org/10.1161/CIRCRESAHA.116.302317">Publisher Full Text </a> | <a target=xrefwindow id=d93475e3737 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4380242">Free Full Text </a></span></li><li><a name=ref-110 class=n-a></a><span class=label>110. </span>&nbsp;<span class=citation><a name=d93475e3746 class=n-a></a>Yang Y, Lv J, Jiang S, <i> et al.</i>: The emerging role of Toll-like receptor 4 in myocardial inflammation. <i>Cell Death Dis.</i> 2016; <b>7</b>: e2234. <a target=xrefwindow id=d93475e3757 href="http://www.ncbi.nlm.nih.gov/pubmed/27228349">PubMed Abstract </a> | <a target=xrefwindow id=d93475e3760 href="http://dx.doi.org/10.1038/cddis.2016.140">Publisher Full Text </a> | <a target=xrefwindow id=d93475e3764 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4917669">Free Full Text </a></span></li><li><a name=ref-111 class=n-a></a><span class=label>111. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727280394"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e3773 class=n-a></a>Xiong X, Liu Y, Mei Y, <i> et al.</i>: Novel Protective Role of Myeloid Differentiation 1 in Pathological Cardiac Remodelling. <i>Sci Rep.</i> 2017; <b>7</b>: 41857. <a target=xrefwindow id=d93475e3784 href="http://www.ncbi.nlm.nih.gov/pubmed/28165494">PubMed Abstract </a> | <a target=xrefwindow id=d93475e3787 href="http://dx.doi.org/10.1038/srep41857">Publisher Full Text </a> | <a target=xrefwindow id=d93475e3791 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5292962">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727280394">F1000 Recommendation</a></span></li><li><a name=ref-112 class=n-a></a><span class=label>112. </span>&nbsp;<span class=citation><a name=d93475e3804 class=n-a></a>Lavine KJ, Epelman S, Uchida K, <i> et al.</i>: Distinct macrophage lineages contribute to disparate patterns of cardiac recovery and remodeling in the neonatal and adult heart. <i>Proc Natl Acad Sci U S A.</i> 2014; <b>111</b>(45): 1602934. <a target=xrefwindow id=d93475e3815 href="http://www.ncbi.nlm.nih.gov/pubmed/25349429">PubMed Abstract </a> | <a target=xrefwindow id=d93475e3818 href="http://dx.doi.org/10.1073/pnas.1406508111">Publisher Full Text </a> | <a target=xrefwindow id=d93475e3822 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4234568">Free Full Text </a></span></li><li><a name=ref-113 class=n-a></a><span class=label>113. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726798910"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e3831 class=n-a></a>Hong JH, Schaff HV, Nishimura RA, <i> et al.</i>: Mitral Regurgitation in Patients With Hypertrophic Obstructive Cardiomyopathy: Implications for Concomitant Valve Procedures. <i>J Am Coll Cardiol.</i> 2016; <b>68</b>(14): 1497504. <a target=xrefwindow id=d93475e3842 href="http://www.ncbi.nlm.nih.gov/pubmed/27687190">PubMed Abstract </a> | <a target=xrefwindow id=d93475e3845 href="http://dx.doi.org/10.1016/j.jacc.2016.07.735">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726798910">F1000 Recommendation</a></span></li><li><a name=ref-114 class=n-a></a><span class=label>114. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725843132"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d93475e3859 class=n-a></a>Ferrazzi P, Spirito P, Iacovoni A, <i> et al.</i>: Transaortic Chordal Cutting: Mitral Valve Repair for Obstructive Hypertrophic Cardiomyopathy With Mild Septal Hypertrophy. <i>J Am Coll Cardiol.</i> 2015; <b>66</b>(15): 168796. <a target=xrefwindow id=d93475e3870 href="http://www.ncbi.nlm.nih.gov/pubmed/26449139">PubMed Abstract </a> | <a target=xrefwindow id=d93475e3873 href="http://dx.doi.org/10.1016/j.jacc.2015.07.069">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725843132">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 07 Sep 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-1659&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-1659&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Cardiovascular Medicine, Heart and Vascular Institute , Cleveland Clinic, Cleveland, Ohio, USA<br/> <sup>2</sup> Center for Clinical Genomics, Cleveland Clinic, Cleveland, Ohio, USA<br/> <p> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-1659/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 07 Sep 2017, 6:1659 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.11669.1">https://doi.org/10.12688/f1000research.11669.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden">  2017 Alvarez P and Tang WW. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=12604 data-id=11669 data-downloads="" data-views="" data-scholar="10.12688/f1000research.11669.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-1659/v1/pdf?article_uuid=73544a41-b6e5-40f3-9756-87a273bfb60c" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.11669.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Alvarez P and Tang WW. Recent Advances in Understanding and Managing Cardiomyopathy [version 1; peer review: 2 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1659 (<a href="https://doi.org/10.12688/f1000research.11669.1" target=_blank>https://doi.org/10.12688/f1000research.11669.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=11669 id=mobile-track-article-signin-11669 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/11669?target=/articles/6-1659"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=12604 /> <input name=articleId type=hidden value=11669 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Barry H Greenberg</strong>, Department of Medicine, Division of Cardiovascular Medicine, University of California San Diego Medical Center, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Hector Ventura</strong>, Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, University of Queensland School of Medicine, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 07 Sep 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-1659&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-1659&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=25465-25793></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=4703-25794></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-1659/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>07 Sep 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Barry H Greenberg</strong>, Department of Medicine, Division of Cardiovascular Medicine, University of California San Diego Medical Center, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Hector Ventura</strong>, Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, University of Queensland School of Medicine, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-1659&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-1659/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent Advances in Understanding and Managing...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-1659/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-1659/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-1659/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Alvarez P and Tang WW');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-1659/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-1659",
            templates : {
                twitter : "Recent Advances in Understanding and Managing Cardiomyopathy. Alvarez P and Tang WW, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-1659/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent Advances in Understanding and Managing Cardiomyopathy", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent Advances in Understanding and Managing Cardiomyopathy", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/11669/12604")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "12604");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "25793": 0,
                           "25794": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "9d332931-677d-49e6-8a88-3299b592caa7";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1659.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1659.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1659.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-1659.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-1659.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>